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	 Obesity	 and	 its	 associated	 complications	 (metabolic	
syndrome)	are	a	major	health	concern	due	to	their	influence	on	quality	
of	life,	morbidity	and	mortality.	In	addition,	they	represent	a	significant	
cost	 to	 Health	 Systems	 (Popkin	 et	 al.	 2012;	 Wang	 et	 al.	 2011).	 The	
etiopathogenesis	 of	 obesity/metabolic	 syndrome	 (OB/MS)	 is	
multifactorial	 and	 includes	 genetic	 factors,	 sedentary	 life	 style	 and	
over-nutrition	 (Gonzalez-Bulnes	 et	 al.	 2016;	 Riccardi	 et	 al.	 2004).	
Regarding	 the	 latter,	 intake	 of	 energy	 dense	 foods	 (fast	 food)	 is	 a	
substantial	problem	in	the	Western	World,	that	is	associated	to	OB/MS	
both	 in	 children	 and	 adults	 (Salazar	 et	 al.	 2006).	 	 In	 addition	 to	 the	
increase	 in	 body	weight,	 OB/MS	 is	 characterized	 by	 changes	 in	 blood	
profile	 that	 include:	 dyslipidemia	 (increased	plasma	 concentrations	of	
triglycerides	 and	 cholesterol)	 (Sastre	 et	 al.	 2013),	 type	 II	 diabetes	
(increased	 blood	 glucose	 and	 insulin),	 and	 changes	 in	 circulating	
adipokines	 (e.g.	 hyperleptinemia)	 (Cheng	 et	 al.	 2012).	 Rodent	models	





	 Mineral	 metabolism	 pivots	 around	 the	 homeostasis	 of	 two	
major	minerals:	calcium	(Ca)	and	phosphorus	(P).	In	vertebrates,	body	
Ca	 and	 P	 is	 preferentially	 located	 in	 the	 skeleton.	 These	 minerals,	
particularly	 P,	 are	 also	 abundant	 in	 the	 intracellular	 compartment	
(Jüpnner,	 2011).	 Extracellular	 concentrations	 of	 Ca	 and	 P	 are	 tightly	
regulated	 by	 a	 complex	 hormonal	 system	 that	 includes:	 parathyroid	
hormone	 (PTH),	 calcitriol	 (CTR)	 and	 fibroblast	 growth	 factor	 23	
(FGF23)	(Quinn	et	al.	2013).	
	 Parathyroid	 hormone	 is	 secreted	 by	 the	 chief	 cells	 of	 the	













	 Calcitriol	 is	 the	 main	 metabolite	 of	 vitamin	 D.	 Vitamin	 D	
(cholecalciferol)	is	ingested	with	food	and,	in	some	species,	may	also	be	
synthesized	 in	 the	 skin.	 Subsequently,	 cholecalciferol	 undergoes	
hydroxylation	in	the	 liver	giving	rise	to	25-cholecalciferol	(calcidiol),	a	
vitamin	 D	 metabolite	 with	 minor	 biological	 activity	 but	 that	 is	 very	
useful	 as	 a	marker	of	 vitamin	D	 intake	 (Blomberg-Jensen	et	 al.	 2010).	
Thereafter,	 calcidiol	 is	 hydroxylated	again	 in	 the	kidney	 to	 form	1,25-
dihydroxyvitamin	D	 (calcitriol),	 the	most	 active	 vitamin	D	metabolite.	
Calcitriol	 is	 further	 metabolized	 to	 other	 compounds	 that	 have	 slight	
activity,	 like	 24,25-dihydroxyvitamin	 D	 (Honkakoski	 and	 Negishi,	
2000).	Calcitriol	actions	are	aimed	to	elevate	both	extracellular	Ca	and	
P	 by	 increasing	 bone	 resorption	 and	 intestinal	 absorption	 of	 these	
minerals.	 	 As	mentioned	 above,	 CTR	 production	 is	 stimulated	 by	 PTH	
and,	in	turn,	CTR	also	regulates	PTH	–	it	does	inhibit	PTH	synthesis	and	
proliferation	 of	 parathyroid	 cells.	 Therefore,	 a	 feed-back	 loop	 that	
regulates	 CTR	 and	 PTH	 is	 established	 between	 the	 kidneys	 and	 the	
parathyroid	glands	(Prosser	and	Jones,	2004).	
	 Fibroblast	 growth	 factor	 23	 (FGF23),	 a	 recently	 discovered	
phosphatonin,	 is	 synthetized	 by	 osteocytes/osteoblasts	 to	 promote	
phosphaturia.	To	 increase	urinary	excretion	of	P,	FGF23	needs	to	bind	
to	 its	 receptors	 (FGFRs)	 and	 to	 a	 co-receptor,	 alfa-klotho	 (commonly	
named	 just	 klotho)	 (Muñoz-Castañeda	 et	 al.	 2017;	 Hu	 et	 al.	 2010).	
Fibroblast	growth	factor	23	is	regulated	by	both	CTR	and	PTH.	Calcitriol	
is	a	major	stimulant	of	FGF23	synthesis	and	in	turn,	FGF23	inhibits	CTR	
production.	 Thus	 a	 second	 feed-back	 loop	 can	 be	 identified	 between	
kidney	 and	 bone	 (Martin	 et	 al.	 2010).	 Parathyroid	 hormone	 is	 also	
known	 to	 stimulate	FGF23	 synthesis,	 in	part	 by	 a	direct	 action	 and	 in	









point	 out	 to	 an	 inhibitory	 effect	 of	 FGF23	 on	 PTH	 (Kawakami	 et	 al.	
2017;	Krajisnik	et	al.	2007).	This	generates	the	third	feed-back		loop	in	
mineral	metabolism	that	connects	bone	and	the	parathyroid	glands.	In	
addition	 to	 its	 contribution	 to	 mineral	 metabolism,	 FGF23	 is	 an	
important	 metabolite	 because	 different	 studies	 have	 demonstrated	 a	
direct	 relationship	 between	 circulating	 levels	 of	 FGF23	 and	
cardiovascular	 mortality	 both	 in	 uremic	 patients	 and	 in	 the	 general	
population	(Ali	et	al.	2014;	Stompor,	2014).	
	 Focussing	 on	 P	 metabolism,	 the	 main	 topic	 of	 this	 Thesis,	 P	
enters	 the	body	 through	the	gastrointestinal	 tract	after	being	 ingested	
with	 foods	 (Marks	 et	 al.	 2013).	 Intestinal	 absorption	 of	 P	 takes	 place	
mainly	 in	 the	 small	 intestine	 both	 by	 passive	 and	 active	 transport	
mechanisms	 in	 which	 are	 implicated	 sodium-phosphate	 co-
transporters	(NaPis),	mainly	NaPiIIb	(Lee	and	Marks,	2015)	Part	of	the	
ingested	 P	 is	 eliminated	with	 the	 feces.	 The	 absorbed	 P	 enters	 blood	
where	it	is	kept	relatively	constant	at	levels	around	1	mM	by	moving	P	
inside	 the	 cells	 and	 into	 the	 skeleton	 and	 by	 excreting	 P,	 mainly	 by	
urine.	 Extracellular	 P	 is	 maintained	 within	 physiologic	 limits	 by	 the	
combined	action	of	PTH	(that	tends	to	decrease	plasma	P	by	promoting	
phosphaturia),	 CTR	 (that	 elevates	 plasma	 P	 by	 facilitating	 enteric	
absorption	 of	 P	 and	 movement	 of	 P	 from	 bone	 to	 the	 extracellular	
compartment)	 and	 FGF23	 (that,	 like	 PTH,	 decreases	 plasma	 P	 by	
increasing	 phosphaturia)	 (Rafi	 and	 Razzaque,	 2017).	 Thus,	 urinary	
excretion	of	P	plays	a	central	role	in	P	homeostasis	and	is	achieved	by	
inhibiting	P	reabsorption	in	the	proximal	tubules.	Both	PTH	and	FGF23	
down-regulate	 the	main	 sodium-phosphate	 transporter	 at	 renal	 level,	
NaPiIIa,	thus	favoring	urinary	excretion	of	P	(Tani	et	al.	2007).	
	 Although	 traditionally	 have	 been	 considered	 independent	
regulatory	systems,	there	is	a	growing	evidence	pointing	out	to	a	close	
relationship	 between	 mineral	 metabolism	 and	 energy	 metabolism.	
Examples	 of	 this	 association	 include	 studies	 that	 link	 obesity	 with	









adipokine	 that	 is	 elevated	 in	 obese	 individuals,	 has	 been	 shown	 to	
stimulate	parathyroid	hormone	secretion	(Lopez	et	al.	2017).	Calcitriol	
is	 also	 related	 to	 obesity	 since	 vitamin	 D-receptor	 knockout	 rodents	
display	 a	 lean	 phenotype	 and	 are	 resistant	 to	 obesity	 (Narvaez	 et	 al.	
2009).	 Furthermore,	 mineral	 metabolism	 is	 interrelated	 with	 glucose	
homeostasis	 -magnesium	 has	 protective	 actions	 against	 metabolic	
syndrome	 and	 hypomagnesemia	 is	 associated	 to	 hyperglycemia	 and	
hyperinsulinemia	(Guerrero-Romero	et	al.	2008).	
	 More	 specifically,	 P	 metabolism	 is	 also	 related	 to	 energy	
metabolism.	 	 The	 influence	 of	 P	 on	 glucose	 and	 lipid	metabolism	 has	
been	 known	 for	 a	 long	 time.	 In	 humans,	 hypophosphatemia	 has	 been	
associated	 to	 glucose	 intolerance	 due	 to	 tissue	 insensitivity	 to	 insulin	
(DeFronzo	and	Lang,	1980)	and	glucose	disposal	rate	has	been	reported	
to	increase	after	phosphate	infusion	(Nowicki	et	al.	1996).	Experiments	
in	 rats	 have	 shown	 that	 dietary	 P	 deprivation	 stimulates	 liver	
gluconeogenesis	 and	 glucogenolysis	 suggesting	 that	 the	 liver	 may	 be	
implicated	 in	 the	 modulation	 of	 glucose	 homeostasis	 induced	 by	 P	
deficiency	(Xie	et	al.	1999;		Xie	et	al.	2000).	In	mice,	dietary	P	restriction	
has	 been	 reported	 to	 induce	 lipid	 accumulation	 in	 the	 liver	 through	
dysregulation	 of	 genes	 involved	 in	 the	 hepatic	 metabolism	 of	
cholesterol	 (Tanaka	 et	 al.	 2013).	More	 recently,	 Abuduli	 et	 al.	 (2016)	
have	 described	 with	 detail	 the	 influence	 of	 dietary	 phosphate	 on	
glucose	 and	 lipid	 metabolism,	 demonstrating	 an	 effect	 not	 only	 of	 P	
restriction	but	also	of	increased	P	intake.	Their	data	show	that	a	high	P	
diet	 improves	 glucose	 regulation,	 down-regulates	 hepatic	 lipid	
synthesis	and	increases	the	expression	of	proteins	that	prevent	visceral	
fat	 accumulation.	 The	 relationship	 between	 dietary	 P	 and	 energy	
metabolism	is	bidirectional.	As	explained	above,	P	can	regulate	energy	
metabolism	 but	 it	 is	 also	 known	 that	 energy	 intake	 modulates	
parameters	 related	 to	 P	 regulation.	 Leptin,	 an	 adipokine	 that	 has	 a	








consistently	 increased	 in	 obesity	 (Pan	 and	 Myers,	 2018),	 has	 been	
shown	 to	 regulate	 the	 synthesis	 and	 secretion	 of	 FGF23	 (Tsuji	 et	 al.	
2010).	
	 Western	 diets	 that	 promote	 OB/MS	 due	 to	 their	 high	 caloric	
content	 are	 also	 typically	 rich	 in	 P	 (Popking	 et	 al.	 2012;	 Wang	 et	 al.	
2011).	In	addition	to	proteins,	the	use	of	P	as	a	food	additive	increases	
the	 P	 content	 of	many	 processed	 foods	 (Sarathy	 et	 al.	 2008;	 Uribarri	
and	 Calvo,	 2003).	 Moreover,	 the	 P	 used	 as	 an	 additive	 is	 inorganic	 P	
which	 is	 much	 more	 readily	 absorbed	 in	 the	 intestine	 than	 the	 P	
naturally	contained	in	foods	(Frommelt	et	al.	2014).	As	a	consequence,	
individuals	 eating	 processed	 fast	 food	 are	 often	 exposed	 to	 both	 and	
excess	of	calories	and	P.	Since	P	is	readily	excreted	by	urine,	P	overload	
is	not	 critical	when	 the	kidneys	are	healthy.	However,	with	decreased	




decline	 in	 renal	 function,	 may	 be	 related	 to	 OB/MS.	 In	 fact,	 diabetic	
nephropathy	 is	 a	major	 cause	 of	 CKD	 in	 humans	 (Gheith	 et	 al.	 2016).	
Independent	 of	 its	 etiology,	 CKD	 always	 results	 in	 severe	 changes	 in	
mineral	 metabolism	 that	 are	 usually	 referred	 to	 as	 secondary	
hyperparathyroidism	 (SHPTH)	 or	 chronic	 kidney	 disease-metabolic	
bone	 disease	 (CKD-MBD)	 (Cozzolino	 et	 al.	 2005).	 Patients	 with	 CKD,	
cannot	 correctly	 eliminate	 P	 by	 urine	 and	 this	 leads	 to	 a	 tendency	 to	
hyperphosphatemia.	 Renal	 synthesis	 of	 CTR	 is	 also	 compromised	 in	
CKD	 and	 the	 decreased	 CTR	 concentrations	 determine	 a	 tendency	 to	
hypocalcemia.	 To	 maintain	 extracellular	 P	 and	 Ca	 within	 physiologic	
levels	 the	parathyroid	 glands	 increase	 synthesis	 and	 secretion	of	 PTH	
that,	in	addition	to	increase	phosphaturia,	promotes	bone	resorption	to	
restore	 extracellular	 Ca	 levels.	 Progression	 of	 CKD	 results	 in	
aggravation	 of	 SHPTH	 and	 a	 progressive	 demineralization	 of	 the	









of	 CKD	 patients	 is	 typically	 characterized	 by	 elevated	 plasma	
concentrations	of	PTH	and	FGF23	and	decreased	concentrations	of	CTR	
(Rodriguez	et	al.	2012).	
	 One	 of	 the	 major	 complications	 of	 CKD-MBD	 is	 the	
development	of	extraskeletal	calcification.	Mineralization	of	soft	tissues,	
particularly	 vascular	 calcification	 (VC),	 is	 very	 important	 because	 it	 is	








	 The	 mechanisms	 by	 which	 OB/MS	 may	 contribute	 to	 the	
severity	of	VC	are	more	likely	multifactorial	and	include	changes	in	lipid	
and	adipokine	profile	(Irribarren	et	al.	2007),	diabetes	mellitus	(Towler	
et	 al.	 1998),	 inflammation	 (Guerrero	 et	 al.	 2011)	 and	 oxidative	 stress	
(Mody	 et	 al.	 2001).	 Recent	 studies	 in	 obese	 Zucker	 rats	 fed	
normocaloric	 diets	 have	 demonstrated	 that	 oxidative	 stress	 plays	 an	
important	 role	 in	 the	 development	 of	 VC.	 Moreover	 in	 these	 studies	












Yamanaka-Okumura,	 H.,	 Sakaue,	 H.,	 Yamamoto,	 H.,	 Takeda,	 E.	 and	
Taketani,	 Y.	 2016.	 Effects	 of	 dietary	 phosphate	 on	 glucose	 and	 lipid	
metabolism.	Am.	J.	Physiol.	Endocrinol.	Metab.,	310:E526-38.	
Ali,	 F.N.,	 Falkner,	 B.,	 Gidding,	 S.S.,	 Price,	 H.E.,	 Keith,	 S.W.	 and	 Langman,	 C.B.	
2014.	Fibroblast	growth	factor-23	in	obese,	normotensive	adolescents	is	
associated	with	adverse	cardiac	structure.	J.	Pediatr.,	165:738-43	
Block,	 G.A.,	 Klassen,	 P.S.,	 Lazarus,	 J.M.,	 Ofsthun,	N.,	 Lowrie,	 E.G.	 and	Chertow,	
G.M.	 2004.	 Mineral	 metabolism,	 mortality,	 and	 morbidity	 in	
maintenance	hemodialysis.	J.	Am.	Soc.	Nephrol.,	15:2208-18.	
Blomberg-Jensen,	M.,	Andersen,	C.B.,	Nielsen,	J.E.,	Bagi,	P.,	Jørgensen,	A.,	Juul,	A.	
and	 Leffers,	 H.	 2010	 Expression	 of	 the	 vitamin	 D	 receptor,	 25-




P.K.	 and	 He,	 J.	 2004.	 The	 metabolic	 syndrome	 and	 chronic	 kidney	
disease	in	U.S.	adults.	Ann.	Intern.	Med.,	140:167-74.	
Cheng,	 S.P.,	 Doherty,	 G.M.,	 Chang,	 Y.C.	 and	 Liu,	 C.L.	 2011.	 Leptin:	 the	 link	
between	 overweight	 and	 primary	 hyperparathyroidism?	 Med.	
Hypotheses,	76:94-6.	


















Gheith,	 O.,	 Farouk,	 N.,	 Nampoory,	 N.,	 Halim,	 M.A.	 and	 Al-Otaibi,	 T.	 2016.	
Diabetic	 kidney	 disease:	 world	 wide	 different	 of	 prevalence	 and	 risk	
factors.	J.	Nephropharmacol.,	5:49-56	
Gonzalez-Bulnes,	 A.,	 Astiz,	 S.,	 Ovilo,	 C.,	 Garcia-Contreras,	 C.	 and	 Vazquez-
Gomez,	 M.	 2016.	 Nature	 and	 Nurture	 in	 the	 Early-Life	 Origins	 of	
Metabolic	Syndrome.	Curr.	Pharm.	Biotechnol.,	17:573-86.	
Guerrero-Romero,	 F.,	 Rascón-Pacheco,	 R.A.,	 Rodríguez-Morán,	M.,	 de	 la	 Peña,	




Lopez,	 I.	 2011.	 The	 effect	 of	 vitamin	 D	 derivatives	 on	 vascular	
calcification	 associated	 to	 inflammation.	 Nephrol.	 Dial.	 Transplant.,	
27:2206-12.	
Honkakoski,	 P.	 and	 Negishi,	 M.	 2000.	 Regulation	 of	 cytochrome	 P450	 (CYP)	
genes	by	nuclear	receptor.	Biochem.	J.,	347:231-7.	










23	 signalling	 in	 the	 parathyroid	 glands	 for	 secondary	
hyperparathyroidism	 in	 mice	 with	 chronic	 kidney	 disease.	 Sci.	 Rep.,	
7:40534.	
Knöpfel,	T.,	Pastor-Arroyo,	E.M.,	Schnitzbauer,	U.,	Kratschmar,	D.V.,	Odermatt,	
A.,	 Pellegrini,	 G.,	 Hernando,	 N.	 and	 Wagner,	 C.A.	 2017.	 The	 intestinal	
phosphate	 transport	 NaPi-IIb	 (Slc34a2)	 is	 required	 to	 protect	 bone	
during	dietary	phosphate	restriction.	Sci.	Rep.,	7:11018.	
Krajisnik,	 T.,	 Björklund,	 P.,	 Marsell,	 R.,	 Ljunggren,	 Ö.,	 Akerström,	 G.,	 Jonsson,	








regulates	 parathyroid	 hormone	 and	 1alpha-hydroxylase	 expression	 in	
cultured	bovine	parathyroid	cell.	J.	endocrinol.,	195:125-31.	
Lee,	C.Y.	2013.	The	effect	of	High-Fat	Diet-Iduced	pathophysiological	Canges	in	
the	 gut	 on	 obesity:	 What	 should	 be	 the	 ideal	 treatment?	 Clinical	 and	
Translational	Gastroenterology,	4e39	
Lee,	 G.L.	 and	 Marks,	 J.	 2015.	 Intestinal	 phosphate	 transport:	 a	 therapeutic	
target	in	chronic	kidney	disease	and	beyond?	Pedriatr.	Nephrol.,	30:363-
71.	
Lopez,	 I.,	 Pineda,	C.,	Raya,	A.I.,	Rodriguez-Ortiz,	M.E.,	Diaz-Tocados,	 J.M.,	Rios,	
R.,	 Rodriguez,	 J.M.,	 Aguilera-Tejero,	 E.	 and	 Almaden,	 Y.	 2017.	 Leptin	
directly	stimulates	parathyroid	hormone	secretion.	Endocrine,	56:675-8.	
Marks,	 J.,	 Debnam,	 E.S.	 and	Unwin,	 R.J.	 2013.	 The	 role	 of	 the	 gastrointestinal	
tract	 in	 phosphate	 homeostasis	 in	 health	 and	 chronic	 kidney	 disease.	
Curr.	Opin.	Nephrol.	Hypertens.,	22:481-7.	





Mody,	 N.,	 Parhami,	 F.,	 Sarafian,	 T.A.	 and	 Demer,	 L.L.	 2001.	 Oxidative	 stress	
modulates	 osteoblastic	 differentiation	 of	 vascular	 and	 bone	 cells.	 Free	
Radic.	Biol.	Med.,	31:509-19.	
Muñoz-Castañeda,	 J.R.,	 Herencia,	 C.,	 Pendón-Ruiz	 de	 Mier,	 M.V.,	 Rodriguez-
Ortiz,	 M.E.,	 Diaz-Tocados,	 J.M.,	 Vergara,	 N.,	 Martínez-Moreno,	 J.M.,	
Salmerón,	 M.D.,	 Richards,	 W.G.,	 Felsenfeld,	 A.,	 Kuro-o,	 M.,	 Almaden,	 Y.	
and	 Rodríguez,	 M.	 2017.	 Differential	 regulation	 of	 renal	 Klotho	 and	
FGFR1	in	normal	and	uremic	rats.	FASEB	J.,	31:3858-67.		
Narvaez,	 C.J.,	 Matthews,	 D.,	 Broun,	 E.,	 Chan,	 M.	 and	 Welsh,	 J.	 2009.	 Lean	
phenotype	and	resistance	to	diet-induced	obesity	in	vitamin	D	receptor	
knockout	 mice	 correlates	 with	 induction	 of	 uncoupling	 protein-1	 in	
white	adipose	tissue.	Endocrinology,	150:651-61.	
Nowicki,	M.,	Fliser,	D.,	Fode,	P.	and	Ritz,	E.	1996.	Changes	in	plasma	phosphate	









Pan,	W.W.	 and	 Myers,	 M.G.Jr.	 2018.	 Leptin	 and	 the	 maintenance	 of	 elevated	
body	weight.	Nat.	Rev.	Neurosci.,	19:95-105.	
Peralta-Ramírez,	A.,	Montes	de	Oca,	A.,	Raya,	A.I.,	Pineda,	C.,	López,	I.,	Guerrero,	
F.,	 Díez,	 E.,	Muñoz-Castañeda,	 J.R.,	Martinez,	 J.,	 Almaden,	 Y.,	 Rodriguez,	
M.	 and	 Aguilera-Tejero	 E.	 2014.	 Vitamin	 E	 protection	 of	 obesity-




Prosser,	 D.E.	 and	 Jones,	 G.	 2004.	 Enzymes	 involved	 in	 the	 activation	 and	
inactivation	of	vitamin	D.	TRENDS	in	Biochem.	Sci.,	29:664-73.	
Quinn,	S.J.,	Thomsen,	A.R.B.,	Pang,	J.L.,	Kantham,	L.,	Bräuner-Osborne,	H.,	Pollak,	
M.,	 Goltzman,	 D.	 and	 Brown,	 E.M.	 2012.	 Interactions	 between	 calcium	
and	phosphorus	in	the	regulation	of	the	production	of	fibroblast	growht	
factor	23	in	vivo.	Am.	J.	Physiol.	Encocrinol.	Metab.,	304:	E310-20	
Rafi,	 S.K.	 and	 Razzaque,	 M.S.	 2017.	 Hormonal	 regulation	 of	 phosphorus	
homeostasis:	 Parathyroid	 Hormone,	 Fibroblast	 Growth	 Factor	 23,	 and	
klotho.	Nutr.	and	Health,	29-44	
Riccardi,	G.,	Giacco,	R.	 and	Rivellese,	A.A.	2004.	Dietary	 fat,	 insulin	 sensitivity	
and	the	metabolic	syndrome.	Clin.	Nutr.,	23:447-56.	
Rodriguez,	M.,	 Lopez,	 I.,	 Muñoz,	 J.,	 Aguilera-Tejero,	 E.	 and	 Almaden,	 Y.	 2012.	
FGF23	 and	 mineral	 metabolism,	 implication	 in	 CKD-MBD.	 Nefrología,	
32:275-8	
Salazar-Martinez,	E.,	Allen,	B.,	 Fernandez-Ortega,	C.,	Torres-Mejia,	G.,	Galal,	O.	
and	 Lazcano-Ponce,	 E.	 2006.	 Overweight	 and	 obesity	 status	 among	
adolescents	from	Mexico	and	Egypt.	Arch.	Med.	Res.,	37:535-42.	
Sarathy,	 S.,	 Sullivan,	 C.,	 Leon,	 J.B.,	 Sehgal,	 A.R.	 2008.	 Fast	 food,	 phosphorus-
containing	additives,	and	the	renal	diet.	J.	Ren.	Nutr.,	18:466-70.		
Sastre,	C.,	Rubio-Navarro,	A.,	Buendía,	I.,	Gómez-Guerrero,	C.,	Blanco,	J.,	Mas,	S.,	
Egido,	 J.,	 Blanco-Colio,	 L.M.,	 Ortiz,	 A.	 and	 Moreno,	 J.A.	 2013.	
Hyperlipidemia-associated	renal	damage	decreases	Klotho	expression	in	
kidneys	from	ApoE	knockout	mice.	PLoS	One,	8:e83713.	















Tani,	 Y.,	 Sato,	 T.,	 Yamanaka-Okumura,	H.,	 Yamamoto,	H.,	 Arai,	H.,	 Sawada,	N.,	
Genjida,	K.,	Taketani,	Y.	And	Takeda,	E.	2007.	Effects	of	prolonged	high	
phosphorus	 diet	 on	 phosphorus	 and	 calcium	 balance	 in	 rats.	 J.	 Clin.	
Biochem.	Nutr.,	40:221-8.	
Towler,	 D.A.,	 Bidder,	 M.,	 Latifi,	 T.,	 Coleman,	 T.	 and	 Semenkovich,	 C.F.	 1998.	
Diet-induced	diabetes	activates	an	osteogenic	gene	regulatory	program	
in	 the	aortas	of	 low	density	 lipoprotein	 receptor-deficient	mice.	 J.	Biol.	
Chem.,	273:30427-34.	
Tremblay,	 A.	 and	 Gilbert,	 J.A.	 2011.	 Human	 obesity:	 is	 insufficient	
calcium/dairy	intake	part	of	the	problem?	J.	Am.	Coll.	Nutr.,	30:449S-53S.	
Tsuji,	K.,	Maeda,	T.,	Kawane,	T.,	Matsunuma,	A.	 and	Horiuchi,	N.	2010.	Leptin	
stimulates	 fibroblast	 growth	 factor	 23	 expression	 in	 bone	 and	
suppresses	 renal	 1alpha,25-dihydroxyvitamin	 D3	 synthesis	 in	 leptin-
deficient	mice.	J.	Bone	Miner.	Res.,	25:1711-23.	
Uribarri,	 J.	and	Calvo,	M.S.	2003.	Hidden	sources	of	phosphorus	 in	 the	 typical	
American	diet:	does	it	matter	in	nephrology?	Semin.	Dial.,	16:186-8.	
Villa-Bellosta,	 R.,	Millan,	 A.	 and	 Sorribas,	 V.	 2011.	 Role	 of	 calcium-phosphate	
deposition	 in	 vascular	 smooth	 muscle	 cell	 calcification.	 Am.	 J.	 Physiol.	
Cell	Physiol.,	300:C210-20.		
Wang,	 B.,	 Chandrasekera,	 P.C.	 and	 Pippin,	 J.J.	 2014.	 Leptin-	 and	 Leptin	
Receptor-Deficient	 Rodent	 Models:	 Relevance	 for	 Human	 Type	 2	
Diabetes.	Curr.	Diabetes	Rev.,	10:131-45.	










































	 This	 Thesis	 is	 based	 on	 the	 general	 Hypothesis	 that	 Mineral	
Metabolism	and	Energy	Metabolism	are	linked.	More	specifically	it	was	
hypothesized	that		abundant	energy	intake	in	the	form	of	high	fat	diets	
would	 modify	 mineral	 metabolism	 (blood	 minerals,	 calciotropic	
hormones,	soft	tissue	mineralization)	both	in	healthy	individuals	and	in	
subjects	with	decreased	renal	function.	




2. To	evaluate	 the	 influence	of	 feeding	a	high	 fat	diet	 on	 the	axis	
fibroblast	growth	factor	23/alfa-klotho	in	rats	with	normal	and	
decreased	renal	function.	
3. To	 investigate	 changes	 in	 calciotropic	 hormones	 (parathyroid	
hormone,	calcitriol,	calcidiol,	etc.)	after	feeding	high	fat	diets	to	
rats	with	normal	and	decreased	renal	function.	
4. To	 evaluate	 the	 influence	 of	 feeding	 a	 high	 fat	 diet	 on	 the	
development	 of	 vascular	 calcification	 in	 uremic	 rats	 with	 and	
without	calcitriol	treatment.	
5. To	 investigate	 the	 influence	 of	 vitamin	 E	 supplementation	 on	
uremic	vascular	calcification	in	rats	fed	high	fat	diets.	
6. To	evaluate	whether	reducing	phosphorus	load	by	feeding	a	diet	




















































	 Rats	 with	 normal	 renal	 function	 (Experiment	 1,	 n=12)	 and	




diets	 with	 NF	 or	 HF.	 Feeding	 the	 HF	 diets	 resulted	 in	 significant	
elevation	of	plasma	FGF23	vs	rats	fed	NF	diets:	Experiment	1,	593±126	
vs	 157±28	 pg/ml	 (p<0.01);	 Experiment	 2,	 538±105	 vs	 250±18	 pg/ml	
(p<0.05);	Experiment	3,	971±118	vs	534±40	pg/ml	 (p<0.01).	Rats	 fed	
HF	 diets	 showed	 P	 retention	 and	 decreased	 renal	 klotho	 (ratio	
klotho/actin)	 vs	 rats	 fed	 NF	 diets:	 Experiment	 1,	 0.75±0.06	 vs	
0.97±0.02	 (p<0.01);	 Experiment	 2,	 0.69±0.07	 vs	 1.12±0.08	 (p<0.01);	
Experiment	3,	0.57±0.19	vs	1.16±0.15	(p<0.05).	Uremic	rats	fed	HF	diet	
showed	more	 severe	 vascular	 calcification	 (VC)	 than	 rats	 fed	 NF	 diet	
(aortic	 Ca=6.3±1.4	 vs	 1.4±0.1	 mg/g	 tissue,	 p<0.001).	 	 In	 conclusion,	
energy-rich	diets	increased	plasma	levels	of	FGF23,	a	known	risk	factor	
of	 cardiovascular	 morbidity	 and	 mortality.	 Even	 though	 FGF23	 has	











	 Energy-dense	 foods	 (fast-foods)	 are	 implicated	 in	 the	
etiopathogenesis	of	dysmetabolic	 syndrome,	a	 significant	and	growing	
health	problem	both	 in	Western	and	developing	countries	(Popking	et	
al.	 2012;	Wang	 et	 al.	 2011).	 In	 addition	 to	 their	 high	 caloric	 content,	
these	foods	are	usually	rich	in	phosphate	(P),	which	is	widely	used	as	a	
food	additive	(Sarathy	et	al.	2008;	Uribarri	and	Calvo,	2003).	Moreover,	
the	 high	 fat	 content	 of	 fast-food	 is	 likely	 to	 increase	 P	 digestibility	
(Frommelt	et	al.	2014),	further	aggravating	P	load.	Phosphate	overload	
may	cause	an	increase	in	fibroblast	growth	factor	23	(FGF23),	which	is	
a	 known	 factor	 of	 cardiovascular	 risk	 (Panwar	 et	 al.	 2015).	 Although	
there	 is	 an	 increasing	 awareness	 of	 the	 detrimental	 effects	 of	 the	 P	
content	of	fast-food,	the	influence	of	the	caloric	content	of	the	diet	on	P	
balance	has	not	been	studied	in	detail.	
	 Phosphate	 overload	may	 be	 tolerated	when	 renal	 function	 is	
intact;	however,	a	decline	in	renal	function,	which	is	associated	to	high-
fat	 intake	 and	 type	 II	 diabetes	 (Chen	 et	 al.	 2004),	 compromises	 P	
handling.	 In	 fact,	 in	 patients	 with	 chronic	 kidney	 disease	 (CKD),	
elevated	 serum	 phosphate	 plays	 a	 major	 role	 in	 the	 development	 of	
vascular	calcification	(VC)	 (Block	et	al.	2004).	Phosphate	promotes	VC	
through	 a	 series	 of	 mechanisms,	 including	 increased	 serum	 CaxP	
product,	which	 leads	 to	 precipitation	 of	 calcium	 salts,	 and	phenotypic	




(high	 fat	 diet)	 would	 cause	 an	 increase	 in	 FGF23	 in	 an	 attempt	 to	






















	 Ethics	 approval.	 All	 experimental	 protocols	 were	 reviewed	
and	 approved	 by	 the	 Ethics	 Committee	 for	 Animal	 Research	 of	 the	
University	of	Cordoba	(Cordoba,	Spain).	All	protocols	were	carried	out	
in	 accordance	 with	 the	 approved	 guidelines.	 They	 followed	 the	
guidelines	 laid	 down	 by	 the	 Higher	 Council	 of	 Scientific	 Research	 of	
Spain	 following	 the	normal	procedures	directing	 animal	welfare	 (Real	
Decreto	 223/88,	 BOE	 of	 18	 of	 March)	 and	 adhered	 to	 the	
recommendations	included	in	the	Guide	for	Care	and	Use	of	Laboratory	
Animals	 (US	 Department	 of	 Health	 and	 Human	 Services,	 NIH)	 and	
European	 laws	 and	 regulations	 on	 protection	 of	 animals,	 under	 the	
advice	of	specialized	personnel.	
	
	 Animals,	 surgical	 procedures	 and	 diets.	 Three	months-old	
Wistar	rats,	provided	by	the	Animal	Housing	Facilities	of	the	University	
of	 Cordoba	 (Cordoba,	 Spain),	were	housed	with	 a	 12h/12h	 light/dark	
cycle.	Appropriate	measures	were	 taken	to	ensure	animal	welfare	and	
to	 address	 the	basic	 behavioral	 and	physiological	 needs	 of	 rats.	 Renal	
function	was	reduced	by	either	1/2	nephrectomy	(Nx)	or	5/6	Nx.	The	
former	 was	 performed	 by	 unilateral	 Nx	 while	 the	 5/6	 Nx	 was	
accomplished	 in	 a	 two-step	 procedure	 that	 reduces	 the	 original	 renal	
mass	by	five-sixths	 leading	to	uremia.	These	procedures	are	described	




and	 the	 two	 poles	 (2/3	 of	 renal	mass)	were	 ablated.	 The	 kidney	was	
inspected	and	returned	 to	an	anatomically	neutral	position	within	 the	
peritoneal	 cavity.	 The	 abdominal	 wall	 and	 skin	 incisions	 were	 closed	
with	 sutures,	 and	 the	 rat	was	 placed	 back	 into	 its	 home	 cage.	 After	 1	









the	 abdomen.	 The	 right	 kidney	was	 exposed	 and	 unencapsulated,	 the	
renal	 pedicle	was	 clamped	 and	 ligated,	 and	 the	 kidney	was	 removed.	
The	 ligated	pedicle	was	 returned	 to	a	neutral	anatomical	position	and	
the	 abdomen	 and	 skin	 incisions	 closed	 with	 suture	 materials.	 The	





5%	 fat	 concentration	 that	 provided	 Metabolizable	 Energy	 =	 3518	
kcal/kg	(Altromin	C	1000,	Altromin	Spezialfutter	GmbH,	Germany)	or	a	
high	fat	content	 	(HF	diet)	with	a	35%	fat	concentration	that	provided	




	 Experimental	 design.	 Studies	 on	 P	 balance.	 These	
experiments	were	 conducted	with	 the	 rats	housed	 in	metabolic	 cages,	
allowing	daily	control	of	 food	and	water	 intake	and	collection	of	urine	
and	feces.	During	the	first	week	the	animals	were	adapted	to	the	cages	
and	 received	 the	 control	 diet	 with	 0.6%	 P	 and	 normal	 fat	 (NP-NF).	
Then,	rats	were	switched	to	experimental	diets	in	three	Experiments:	
• Experiment	1-	Rats	with	intact	renal	function	were	allotted	to	2	
groups	 (n=6	 each).	 Rats	 in	 group	 1	 were	 fed	 normal	 P	 and	
normal	fat	diet	(NP-NF)	and	rats	in	group	2	were	fed	normal	P	
and	 high	 fat	 diet	 (NP-HF)	 for	 30	 days.	Water	 and	 food	 intake	
were	 recorded	 daily	 during	 the	whole	 experiment.	 During	 the	
last	 week	 of	 the	 trial	 feces	 and	 urine	 were	 collected	 daily	 to	










• Experiment	 2-	 Rats	 with	 reduced	 (1/2	 Nx)	 renal	 function	
(n=12)	were	fed	either	normal	P	and	normal	fat	(NP-NF,	n=6)	or	
normal	P	and	high	 fat	 (NP-HF,	n=6)	diet	 for	30	days,	 following	
the	same	protocol	as	in	Experiment	1.	
• Experiment	3-	Rats	with	intact	renal	 function	were	fed	HP	diet	
(1.2%	 P)	 and	 were	 allotted	 to	 2	 groups	 (n=6	 each).	 Rats	 in	
group	1	were	 fed	normal	 fat	 diet	 (HP-NF)	 and	 rats	 in	 group	2	




development	 of	 VC	 in	 uremic	 rats.	 Sixteen	 rats	were	 fed	 a	 NP	
diet	 with	 either	 normal	 fat	 content	 (NP-NF,	 n=6)	 or	 high	 fat	
content	 (NP-HF,	 n=10)	 for	 45	 days.	 At	 day	 45	 the	 first	 step	 of	
the	 5/6	 Nx	 was	 conducted	 and	 a	 week	 later	 the	 5/6	 Nx	 was	
completed	(day	52).	After	 the	second	step	of	5/6	Nx	rats	were	
switched	 to	 a	 HP	 (1.2%)	 diet.	 The	 fat	 content	 of	 the	 diet	 was	




	 Blood	 chemistries.	 Blood	 for	 chemistry	 analyses	 was	
obtained	at	 the	 time	of	sacrifice	 (intraperitoneal	 thiopental	anesthesia	
plus	 exsanguination),	 from	 the	 abdominal	 aorta.	 Blood	 for	
measurements	 of	 ionized	 calcium	 levels	 was	 collected	 in	 heparinized	
syringes	 and	 immediately	 analyzed	 using	 a	 Ciba-Corning	 634	 ISE	
Ca2+/pH	Analyzer	 (Ciba-Corning,	Essex,	England).	Afterwards,	plasma	
was	 separated	 by	 centrifugation	 and	 stored	 at	 –20°	 C	 until	 assayed.	
Plasma	creatinine,	urea,	triglycerides,	total	cholesterol,	HDL	cholesterol,	
LDL	cholesterol	and	phosphorus	were	measured	by	spectrophotometry	








plasma	 FGF23	 (Kainos	 Laboratories,	 Tokyo,	 Japan)	 and	 PTH	
(Immutopics,	 San	 Clemente,	 CA).	 Radioimmunoassay	
(Immunodiagnostic	 Systems	 Ltd,	 Boldon,	 UK)	 was	 used	 in	 plasma	
samples	 to	 determine	 25-hydroxyvitamin	 D	 (calcidiol)	 and	 1,25-
dihydroxyvitamin	D	(calcitriol).		
	
	 Urine	 and	 feces	 analysis.	 Fecal	 samples	 were	 dried,	 ashed	
and	 demineralized	 with	 0.6	 mmol/l	 HNO3	 solution.	 Fecal	 P	 was	
measured	 by	 inductively	 coupled	 plasma	 mass	 spectrophotometry	
(ICP-MS,	 Perkin	 Elmer	 Elan	 DRC-e,	 Walthan,	 Massachusetts,	 USA).	
Urinary	phosphorus	was	measured	by	spectrophotometry	(BioSystems	




	 Protein	 extraction	 and	 Western	 blot	 analysis.	 Proteins	
were	isolated	from	renal	tissue	by	using	a	lysis	buffer	containing	HEPES	
(10	mmol/l),	KCl	(10	mmol/l),	EDTA	(0.1	mmol/l),	EGTA	(0.1	mmol/l),	
DTT	 (1	 mmol/l),	 PMSF	 (0.5	 mmol/l),	 protease	 inhibitor	 cocktail	 (70	
µg/ml),	 and	 I-Gepal	 CA-630	 (0.6%),	 pH	 7.9	 (Sigma	 Aldrich,	 St.	 Louis,	
MO).	 Protein	 concentration	was	 determined	 by	 Bradford	method.	 For	
Western	Blot	analysis,	50	µg	of	protein	were	electrophoresed	on	a	10%	
SDS-polyacrylamide	 gel	 (Invitrogen,	 Carlsbad,	 CA)	 and	
electrophoretically	 transferred	 (Transfer	 Systems,	 BioRad,	 Hercules,	
CA)	 from	 the	 gels	 onto	 nitrocellulose	 membranes	 (Invitrogen).	 The	
following	steps	were	performed	with	gentle	shaking.	Membranes	were	




(1) P net absorption (mg day) = P intake – P fecal excretion	








without	 nonfat	 dry	 milk)	 and	 incubated	 for	 2	 hours	 at	 room	
temperature	with	 a	mouse	 anti-FGFR1	 antibody	 (GeneTex,	 Irvine,	 CA;	
0.5	 µg/ml)	 or	 rat	 anti-klotho	 antibody	 (Alpha	 Diagnostic	 Int.,	 San	
Antonio,	TX;	0.5	µg/ml).	The	membranes	were	then	washed	with	TTBS	
buffer	 and	 immunolabeled	 using	 a	 peroxidase-conjugated	 secondary	
antibody	 (1:5000	 dilution;	 Santa	 Cruz	 Biotechnology	 Inc.,	 Santa	 Cruz,	
CA).	 Finally,	 they	 were	 revealed	 on	 autoradiographic	 film	 using	 ECL	
Plus	 Western	 Blotting	 Detection	 System	 (GE	 Healthcare,	 Piscataway,	




	 Real-Time-Polymerase	 Chain	 Reaction	 (RT-PCR).	 Study	of	
bone	 FGF23	 and	 aortic	 Runx-2,	 Osterix	 and	 Sclerostin	 mRNA	 was	
performed	 by	 Quantitative	 Real-Time	 PCR.	 Tibial	 bone	 or	 aorta	 were	
disrupted	using	liquid	nitrogen	and	grinded	thoroughly	with	a	mortar.	
Aortic	total	RNA	was	extracted	from	the	lysate	using	RNA	extraction	kit	
(RNeasy	 Fibrous	 Tissue	 Mini	 Kit,	 Qiagen,	 Germany).	 Bone	 RNA	 was	
extracted	 using	 the	 chloroform	 and	 isopropanol	 precipitation	method	
and	 a	 treatment	 with	 DNAse	 I	 Amplification	 Grade	 (Sigma-Aldrich).	
Fifty	 ng	 of	 total	 RNA	 were	 used	 to	 analyze	 mRNA	 expression	 in	 the	
LightCycler	thermal	cycler	system	(Roche	Diagnostics,	Indianapolis,	IN,	
USA).	 RT-PCR	was	 performed	 in	 one	 step,	 using	 the	QuantiTect	 SYBR	
Green	 RT-PCR	 kit	 (Qiagen	 GmbH,	 Hilden,	 Germany)	 following	 the	
manufacturer’s	protocol.		Primers	for	Runx-2,	Osterix	and	GAPDH	were	
designed	 with	 the	 free	 Oligo	 7	 software.	 The	 Sclerostin	 primer	 was	










	 The	 expression	 of	 target	 genes	was	 normalized	 to	GAPDH	 as	
housekeeping	and	calculated	according	to	the	2∆(∆CT)	method.	
	
	 Assessment	 of	 vascular	 calcification	 (VC).	 Following	
sacrifice,	 the	 thoracic	 aorta,	 stomach	 and	 lungs	 were	 dissected	 and	
processed	 to	 study	 mineral	 content.	 Calcification	 was	 studied	 by	
measuring	the	tissue	calcium	and	phosphorus	content.	The	tissues	were	
demineralized	 in	 10%	 formic	 acid	 (aorta)	 and	 150	mM	HCl	 (stomach	
and	 lungs).	The	calcium	and	phosphorus	content	was	measured	 in	 the	
supernatant	 according	 to	 a	method	previously	 described	 (Lopez	 et	 al.	
2006).	Fresh	tissue	was	also	fixed	in	10%	buffered	formalin,	embedded	





(SE).	 The	 difference	 between	 means	 for	 two	 different	 groups	 was	
determined	by	 t-test;	 the	difference	between	means	 for	 three	or	more	
groups	 was	 assessed	 by	 Analysis	 of	 Variance	 (ANOVA).	 	 Fisher	 Least	
Significant	 Difference	 (LSD)	 test	was	 used	 as	 a	 post-hoc	 procedure.	 A	





















(NP)	 and	 either	 normal	 fat	 (NF)	 or	 high	 fat	 (HF);	 and	 in	 rats	 with	
normal	 renal	 function	 fed	 high	 P	 (HP)	 diets	 with	 NF	 or	 HF.	 In	 all	





in	 NF	 vs	 HF	 groups:	 rats	 with	 intact	 renal	 function	 fed	 NP,	 44.5±3.2	
mg/day	 vs	 44.1±2.4	mg/day;	 1/2Nx	 rats	 fed	 NP,	 42.1±1.6	mg/day	 vs	
47.3±2.0	 mg/day;	 rats	 with	 intact	 renal	 function	 fed	 HP,	 94.5±6.5	
mg/day	 vs	 95.9±4.2	mg/day.	Urinary	 P	 excretion	was	 not	 different	 in	
rats	fed	HF	or	NF	and	NP.	In	rats	fed	HP,	P	excretion	by	urine	was	lower	
(p<0.05)	in	rats	fed	HF	diet,	85.0±3.6	mg/day,	than	in	rats	fed	NF	diet,	
101.3±4.0	 mg/day.	 In	 rats	 with	 intact	 renal	 function	 fed	 NP,	 a	 non-
significant	tendency	to	P	retention	was	detected	with	HF	diet,	14.8±1.8	
mg/day	vs	12.9±2.2	mg/day	in	rats	fed	NF	diet.	Phosphorus	retention	in	
rats	 on	 HF	 diets	 became	 significant	 (p<0.05)	 in	 1/2Nx	 rats	 fed	 NP,	
19.3±1.8	mg/day	vs	10.0±2.2	mg/day	in	rats	on	NF	diet,	and	in	rats	fed	
HP,	10.9±4.4mg/day	vs	-6.8±5.2	mg/day	in	rats	on	NF	diet	(Table	1).	
	 In	 the	 groups	 receiving	 NP,	 even	 though	 P	 load	was	 similar,	





had	 significantly	 (p<0.01)	 elevated	 FGF23,	 995±120	 pg/ml,	 when	
compared	 with	 rats	 fed	 HP-NF	 diet,	 547±40	 pg/ml	 (Fig.	 1).	 HF	 diets	
elicited	 increased	expression	of	FGF23	 in	bone.	 In	a	 subset	of	 rats	 fed	













































































































































































































































































































































































































































































































































































































































































































































































Fig.	 1.	 Influence	 of	 the	 fat	 content	 of	 the	 diet	 on	 fibroblast	 growth	 factor	 23	
(FGF23).	 	 Plasma	 concentrations	 of	 FGF23	 in	 rats	 fed	 normal	 fat	 (NF,	 white	
bars	 ☐)	 or	 high	 fat	 (HF,	 black	 bars	 n)	 diets	 in	 the	 studies	 on	 P	 balance.	
Experiment	1	(n=12):	rats	with	intact	renal	function	fed	0.6%	P,	Experiment	2	




	 No	 significant	 differences	 between	 NF	 and	 HF	 groups	 were	
found	 in	 plasma	 concentrations	 of	 P,	 iCa,	 creatinine,	 total	 cholesterol,	
triglycerides	 and	 PTH.	 As	 expected,	 1/2	 Nx	 rats	 had	 higher	 plasma	




diets	 resulted	 in	 significant	 reductions	 in	 plasma	 concentrations	 of	
calcitriol	when	compared	with	rats	 fed	NF	diets:	rats	with	 intact	renal	
function	fed	NP,	11.3±1.1	pg/ml	vs	82.2±11.7	pg/ml	(p<0.001);	1/2Nx	
rats	 fed	NP,	20.8±10.8	pg/ml	vs	117.1±23.7	pg/ml	 (p<0.01);	 rats	with	
intact	 renal	 function	 fed	 HP,	 74.8±25.9	 pg/ml	 vs	 143.0±11.8	 pg/ml	
(p<0.05)	(Table	2).		
	 Figure	2	shows	the	levels	of	klotho	and	FGFR1	proteins	in	the	








plasma	 FGF23	 concentrations.	 A	 significant	 decrease	 in	 renal	 klotho	
(ratio	 klotho/β-actin)	was	 identified	 in	 all	 rats	 fed	HF	diets:	 rats	with	
intact	renal	function	fed	NP,	0.75±0.06	vs	0.97±0.02	in	rats	fed	NF	diet	
(p<0.01);	1/2Nx	rats	fed	NP,	0.69±0.07	vs	1.12±0.08	in	rats	fed	NF	diet	
(p<0.01);	 and	 rats	 with	 intact	 renal	 function	 fed	 HP,	 0.57±0.19	 vs	



















































































































































































	 Studies	 on	 vascular	 calcification	 (VC).	Uremic	 rats	 fed	HP-
NF	 diet	 only	 experienced	 very	 minor	 mineral	 deposition	 in	 vascular	








mg/g	 tissue.	 However,	 5/6	 Nx	 rats	 on	 HP-HF	 diet	 showed	 consistent	
increases	in	both	aortic	calcium	(6.3±1.4	mg/g	tissue)	and	phosphorus	
(12.4±7.2	 mg/g	 tissue),	 p<0.001	 vs	 NF	 diet.	 Similar	 results	 were	
obtained	 in	 other	 soft	 tissues	 and	 extraskeletal	 calcification	 was	 also	
confirmed	 by	 von	 Kossa	 staining	 (Fig.	 3).	 Feeding	 HF	 diets	 not	 only	
resulted	 in	 mineral	 deposition	 but	 also	 in	 a	 phenotypic	
transdifferentiation	 of	 the	 vessel	 wall	 that	 was	 evidenced	 by	 an	
increase	 in	 the	 expression	 of	 osteogenic	 genes.	 Thus,	 mRNA	 Runx-
2/GAPDH	 ratio	was	 increased	 by	 2.8	 fold,	mRNA/GAPDH	Osterix	was	
increased	 by	 2.4	 fold	 and	mRNA	 Sclerostin/GAPDH	was	 increased	 by	
3.8	fold	in	rats	fed	HF	diet	when	compared	with	rats	fed	NF	diet	(Fig.	4).	
	
Fig.	 3.	 Influence	 of	 the	 fat	 content	 of	 the	 diet	 on	 vascular	 calcification.	 	 (A)	
Calcium	 (white	 bars	 ☐)	 and	 phosphorus	 (black	 bars	 n)	 content	 (mg/g	 of	
tissue)	in	the	aortas	of	uremic	(5/6	Nx)	rats	fed	high	1.2%	P	and	either	normal	


















observed	 in	 plasma	 creatinine,	 urea,	 iCa,	 P	 and	 PTH.	 Plasma	
triglycerides,	 LDL	 cholesterol	 and	 HDL	 cholesterol	 tended	 to	 be	
elevated	in	rats	fed	HF	diet	but	significant	differences	with	rats	fed	NF	
diet	were	only	found	in	total	cholesterol	(111.9±6.4	vs	84.2±3.5	mg/dl).	
Plasma	 FGF23	was	 significantly	 higher	 (11,366±1,639	 vs	 4,799±2,402	
pg/ml,	 p<0.05)	 in	 rats	 fed	HF	 diet	 (Table	 3)	 and	was	 correlated	with	
aortic	 calcium	 (r=0.640,	 p=0.001).	 The	 increase	 in	 FGF23	 was	
accompanied	 by	 a	 marked	 but	 non-significant	 decrease	 in	 the	






































	 This	 study	 was	 designed	 to	 investigate	 the	 effect	 of	 feeding	
energy-dense	 diets	 on	 P	 balance	 and	 VC	 in	 rats	 with	 normal	 and	
reduced	renal	 function.	 	Our	results	show	that	rats	 fed	diets	with	high	
fat	 content	 decreased	 renal	 klotho	 expression,	 developed	 P	 retention	
due	 to	 impaired	 renal	 excretion	 of	 P,	 and	 increased	 plasma	 FGF23	
concentrations.	 Moreover,	 uremic	 rats	 fed	 HF	 diets	 showed	 more	
severe	VC	than	their	normocaloric-fed	counterparts.		
	 The	 study	 experimental	 design	 was	 based	 on	 comparing	 the	
effect	 of	 diets	 with	 identical	 P	 concentration	 and	 different	 caloric	
content.	 For	 this	 purpose	 a	 high-fat	 diet,	 which	 is	 commercialized	 to	
induce	obesity	in	rodents,	was	used.	As	previously	reported	(Ainslie	et	
al.	 2011),	 during	 the	 experiments	 the	 rats	 fed	 HF	 diets	 reduced	 food	
consumption	 to	 maintain	 a	 constant	 caloric	 intake	 (around	 50	
kcal/day).	Thus,	after	eating	HF	or	NF	diets	for	30	days,	no	differences	
in	body	weight	were	observed	between	groups.	This	allowed	 to	 study	
the	 effect	 of	 the	 caloric	 content	 of	 the	 diet	 independent	 of	 obesity-
mediated	 mechanisms	 (e.g.	 adipokines	 and	 other	 inflammatory	
mediators	released	by	fat	tissue).	Although	the	reduction	in	food	intake	
in	rats	fed	HF	diets	resulted	in	a	decreased	P	intake,	in	agreement	with	
previous	 reports	 (Frommelt	et	al.	2014)	 the	 intestinal	absorption	of	P	
was	 increased	 in	 rats	 fed	 HF	 diets.	 	 The	 decrease	 in	 P	 intake	 was	
compensated	by	the	increase	in	intestinal	absorption	of	P	in	rats	fed	HF	
diets	resulting	in	almost	identical	P	load	in	HF	vs	NF	groups.	
	 Feeding	 HF	 diets	 was	 consistently	 associated	 to	 increases	 in	
plasma	 FGF23	 concentrations	 in	 all	 experimental	 groups.	 Although	
FGF23	has	been	reported	to	be	increased	in	obese	people	(Marsell	et	al.	
2009)	 and	 a	 recent	 study	 identified	 energy	 intake	 as	 a	 potential	
predictor	of	plasma	FGF23	concentrations	(di	Giussepe	et	al.	2015),	 to	
the	best	of	our	knowledge	this	is	the	first	report	demonstrating	a	direct	
relationship	 between	 ingestion	 of	 a	 high	 calories/high	 fat	 diet	 and	








FGF23	 are	 a	 prognostic	 factor	 for	 cardiovascular	 disease	 in	 patients	
with	 CKD	 (Scialla	 et	 al.	 2014)	 and	 in	 the	 general	 population	
(Kestenbaum	et	 al.	 2014).	Thus,	 the	demonstration	of	 elevated	FGF23	





to	 the	 phosphaturic	 action	 of	 FGF23.	 To	 promote	 phosphaturia	 in	 the	
kidney	tubule,	FGF23	needs	to	bind	to	the	klotho-FGFR	complex	(Kuro-
o,	2010).	Therefore,	the	demonstration	of	reduced	klotho	protein	levels	
in	 the	 kidneys	 of	 rats	 fed	 HF	 diet	 may	 explain	 the	 resistance	 to	 the	
phosphaturic	action	of	FGF23	found	in	the	present	study.		Renal	klotho	
has	 been	 reported	 to	 be	 decreased	 in	 hyperlipidemic	 ApoE	 knockout	
mice	and	the	authors	suggested	that	hyperlipidemia-associated	kidney	
injury	 might	 be	 responsible	 for	 the	 decreased	 renal	 expression	 of	
klotho	 (Sastre	et	 al.	 2013).	While	 the	 renal	 toxicity	of	high	 fat	diets	 is	
well	 documented	 (Boini	 et	 al.	 2014),	 additional	mechanisms	might	 be	
involved	in	the	decrease	of	klotho	induced	by	feeding	HF	diets.	Klotho	
intervenes	in	energy	regulation	at	different	levels	and	klotho	knockout	
mice	 display	 a	 lean	 phenotype	 (Razzaque,	 2012).	 	 Moreover,	 rats	
subjected	 to	 caloric	 restriction	 have	 been	 shown	 to	 increase	 renal	
klotho	 mRNA	 expression	 and	 klotho	 protein	 (Miyazaqui	 et	 al.	 2010).	
Thus,	in	addition	to	renal	toxic	effects,	energy-dense	diets	may	directly	
downregulate	 renal	 klotho.	 Klotho	 down-regulation	 by	 high	 caloric	
intake	 could	 have	 significant	 health	 consequences	 since,	 as	 shown	 in	
this	study,	it	will	lead	to	impaired	renal	excretion	of	P	and	P	retention.	
	 Feeding	 HF	 diets	 resulted	 in	 low	 plasma	 calcitriol	
concentrations	and	calcitriol	was	significantly	lower	in	rats	fed	HF	diets	
than	in	rats	fed	NF	diets.	The	vitamin	D	content	was	identical	in	HF	and	












HF	 diets.	 Since	 calcidiol	 is	 the	 vitamin	 D	metabolite	 that	 best	 reflects	
nutritional	 intake	 (Holick,	 2007),	 the	 origin	 of	 the	 decreased	 plasma	
calcitriol	in	rats	fed	HF	diets	cannot	be	attributed	to	decreased	dietary	




eating	 diets	 with	 high	 fat	 content	 may	 also	 have	 significant	 health	
implications	 because	 vitamin	 D	 deficiency	 is	 associated	 with	
cardiovascular	disease,	diabetes	and	metabolic	syndrome	(Dobnig	et	al.	
2008;	Parker	et	al.	2010).	
	 Extraskeletal	 calcification	 is	 a	 common	 feature	 in	 uremic	
patients	and	VC	represents	an	important	contributor	to	the	high	rate	of	
cardiovascular	 mortality	 associated	 to	 CKD	 (Block	 et	 al.	 2004).	 The	
inability	to	eliminate	P	plays	a	major	role	in	the	development	of	uremic	
VC	(Giachelli,	2009).	Data	from	Experiments	1-3	indicated	that	HF	diets	
resulted	 in	 P	 retention	 particularly	 when	 rats	 were	 fed	 HP	 and,	 to	 a	
lesser	 extent,	 with	moderate	 (1/2	 Nx)	 reduction	 in	 renal	 function.	 In	
Experiment	4	we	evaluated	the	effect	of	feeding	HP-HF	diets	to	uremic	
(5/6	Nx)	rats.	In	contrast	to	rats	fed	HP-NF	diets,	uremic	rats	fed	HP-HF	
diets	 showed	 upregulation	 of	 osteogenic	 genes	 in	 vascular	 tissue	 and	
marked	VC.	In	addition	to	P	retention,	feeding	HF	diets	also	resulted	in	
moderate	 dislipidemia	 which	 may	 also	 have	 contributed	 to	 the	
development	 of	 VC.	 Our	 data	 demonstrate	 that	 although	 P	 retention	
associated	 to	 the	 ingestion	 of	 fast-food	 can	 be	 tolerated	 when	 renal	












	 In	 conclusion,	 after	being	 fed	with	high	 fat	diets	 rats	 showed	
decreased	 renal	 klotho	 expression,	 increased	 circulating	 levels	 of	
FGF23	 and	 decreased	 plasma	 concentrations	 of	 calcitriol.	 Reduced	
klotho	resulted	in	resistance	to	the	phosphaturic	action	of	FGF23	and	P	
retention.	 Moreover,	 uremic	 rats	 fed	 hypercaloric/high	 fat	 diets	
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syndrome,	 obesity	 and	 renal	 disease.	 Previous	 studies	 have	 revealed	
that	 high	 fat	 diets	 promote	 vascular	 calcification	 in	 uremic	 rats.	
Moreover,	vitamin	E	has	been	shown	to	prevent	uremic	calcifications	in	




	 Wistar	 rats	 (n=32)	 were	 preconditioned	 by	 feeding	 either	 a	
normal	 (NF)	 or	 high	 fat	 (HF)	 diet	 for	 45	 days	 and	 subsequently	were	
subjected	to	5/6	nephrectomy	(Nx).	Just	before	performing	the	first	Nx	
step,	 a	 blood	 sample	 (Pre-Nx)	 was	 obtained.	 After	 Nx	 rats	 were	
switched	 to	 a	 diet	 with	 0.9%	 phosphorus	 and	 supplemented	 with	
calcitriol.	Also,	 after	Nx,	half	 of	 the	 rats	 from	each	group	 (NF	and	HF)	
were	 treated	with	vitamin	E	(VitE)	 in	 the	diet	 (30000	mg/kg)	and	 the	
other	 half	 were	 maintained	 on	 basic	 VitE	 requirements	 (27	 mg/kg).	
Thus,	rats	were	allotted	to	four	experimental	groups:	Nx-NF	(n=8),	Nx-
NF-VitE	 (n=8),	 Nx-HF	 (n=8)	 and	 Nx-HF-VitE	 (n=8).	 At	 the	 time	 of	
sacrifice	(day	66),	blood	and	tissue	samples	were	obtained.	
	 Feeding	a	HF	diet	for	45	days	did	not	increase	body	weight	but	
elicited	 hyperglycemia,	 hypertriglyceridemia,	 an	 increase	 in	 plasma	
fibroblast	 growth	 factor	 23	 and	 a	 reduction	 in	 plasma	 calcitriol	
concentrations.	 After	 Nx,	 rats	 fed	 HF	 diet	 showed	 substantial	
extraskeletal	 calcification	with	 aortic	 calcium	 content	 that	was	 higher	
than	 in	 rats	 fed	 NF	 diet.	 Supplementation	 with	 VitE	 significantly	





























sedentary	 lifestyle	 and	 excesive	 intake	 of	 sugar-	 and	 fat	 rich	 foods	




increased	 glomerular	 capillary	 wall	 tension,	 changes	 in	 podocytes,	
down-regulation	 of	 the	 Sirt	 1-adiponectin	 axis,	 etc.	 (Wickman	 and	
Kramer,	2013).	
	 However,	 the	 influence	 of	 OB/MS	 on	 vascular	 calcifications	
(VC),	 one	 of	 the	 major	 contributors	 to	 cardiovascular	 mortality	 in	
patients	with	chronic	kidney	disease	(CKD)	(Block	et	al.	2004),	has	not	
been	studied	with	detail.	When	subjected	to	nephrectomy,	obese	Zucker	
rats	 have	 been	 reported	 to	 develop	 more	 severe	 extraskeletal	
calcifications	 than	 lean	 Zucker	 rats.	 In	 this	 experimental	 model,	 the	
influence	 of	 OB/MS	 on	 calcifications	 seems	 to	 be	 partly	 mediated	 by	
oxidative	stress	and	calcifications	can	be	prevented	by	 treatment	with	
vitamin	E	(VitE)	(Peralta-Ramírez	et	al.	2014).			
	 Moreover,	we	 have	 recently	 shown	 that	 uremic	 rats	 fed	 high	
fat	(HF)	diets	also	develop	more	severe	VC	than	their	counterparts	fed	
normal	 fat	 (NF)	 diets.	 Phosphorus	 (P)	 retention,	 secondary	 to	 renal	
klotho	and	fibroblast	growth	factor	23	(FGF23)	dysregulation,	seems	to	
be	implicated	in	the	procalcifying	effect	of	HF	diet	(Raya	et	al.	2016).	In	
patients	 with	 CKD,	 elevated	 serum	 P	 plays	 a	 major	 role	 in	 the	
development	of	VC	(Ritter	and	Slatopolsky,	2016).	High	extracellular	P	
concentrations	promote	VC	 through	a	 series	of	mechanisms,	 including	








(VSMCs)	 to	 osteogenic	 cells	 and	 increased	 serum	 calcium	 (Ca)xP	
product,	 which	 facilitates	 the	 deposition	 of	 Ca	 salts	 (Giachelli,	 2009;	
Villa-Bellosta	 et	 al.	 2011).	 Since	 high	 P	 also	 has	 been	 reported	 to	
promote	oxidative	stress	 in	VSMCs	(Di	Marco	et	al.	2008),	 it	would	be	
important	 to	determine	whether	antioxidant	 therapy	with	VitE	 is	able	
to	ameliorate	calcifications	in	uremic	rats	fed	a	diet	rich	in	fat.		
	 We	 hypothesized	 that,	 as	 already	 shown	 in	 the	 model	 of	













	 Ethics	 Approval.	 All	 experimental	 protocols	 were	 reviewed	
and	 approved	 by	 the	 Ethics	 Committee	 for	 Animal	 Research	 of	 the	
University	of	Cordoba	(Cordoba,	Spain).	All	protocols	were	carried	out	
in	 accordance	 with	 the	 approved	 guidelines.	 They	 followed	 the	
guidelines	 laid	 down	 by	 the	 Higher	 Council	 of	 Scientific	 Research	 of	
Spain	 following	 the	normal	procedures	directing	 animal	welfare	 (Real	
Decreto	 223/88,	 BOE	 of	 18	 of	 March)	 and	 adhered	 to	 the	
recommendations	included	in	the	Guide	for	Care	and	Use	of	Laboratory	
Animals	 (US	 Department	 of	 Health	 and	 Human	 Services,	 NIH)	 and	





of	 Cordoba	 (Cordoba,	 Spain),	were	housed	with	 a	 12h/12h	 light/dark	
cycle,	 and	 given	 ad	 libitum	 access	 to	 a	 standard	 diet	 with	 normal	
Ca=0.6%	and	P=0.6%.	Uremia	was	induced	by	5/6	nephrectomy	(Nx),	a	
two-step	procedure	that	reduces	the	original	renal	mass	by	five-sixths.	
Briefly,	 animals	 were	 anesthetized	 using	 xylazine	 (5	 mg/kg,	 ip)	 and	
ketamine	(80	mg/kg,	ip).	For	the	first	step	of	the	5/6	Nx,	a	5-	to	8-mm	
incision	was	made	on	the	left	mediolateral	surface	of	the	abdomen.	The	
left	 kidney	was	 exposed,	 and	 the	 two	 poles	 (2/3	 of	 renal	mass)	were	
ablated.	 The	 kidney	 was	 inspected	 and	 returned	 to	 an	 anatomically	
neutral	 position	within	 the	 peritoneal	 cavity.	 The	 abdominal	wall	 and	
skin	 incisions	were	 closed	with	 sutures,	 and	 the	 rat	 was	 placed	 back	
into	 its	 home	 cage.	 After	 1	 week	 of	 recovery,	 in	 the	 second	 step,	 the	
animal	was	reanesthetized	and	a	5-	to	8-mm	incision	was	made	on	the	
right	 mediolateral	 surface	 of	 the	 abdomen.	 The	 right	 kidney	 was	
exposed	 and	 unencapsulated,	 the	 renal	 pedicle	 was	 clamped	 and	
ligated,	and	the	kidney	was	removed.	The	ligated	pedicle	was	returned	








closed	 with	 suture	 materials.	 Fentanyl	 (0.2	 mg/kg,	 ip)	 was	 used	 as	




of	 calcitriol	 has	 been	 previously	 shown	 to	 be	 effective	 in	 controlling	
secondary	hyperparathyroidism.	 Independent	 of	 their	 P	 content,	 diets	
had	either	a	normal	 fat	 content	 (NF	diet)	with	a	5%	 fat	 concentration	
that	provided	Metabolizable	Energy	=	3518	kcal/kg	(Altromin	C	1000,	
Altromin	Spezialfutter	GmbH,	Germany)	or	a	high	fat	content	(HF	diet)	
with	 a	 35%	 fat	 concentration	 that	 provided	 Metabolizable	 Energy	 =	
5241	 kcal/kg	 (Altromin	 C	 1090-60,	 Altromin	 Spezialfutter	 GmbH,	
Germany).	 Sacrifice	 was	 performed	 by	 aortic	 puncture	 and	
exsanguination	of	the	anesthetized	(sodium	thiopental,	ip)	rat.		
	
	 Experimental	 Design.	 Sixteen	 rats	 were	 maintained	 for	 45	
days	 on	NF	diet	 and	16	 rats	 on	HF	diet	 (both	diets	with	0.6%	Ca	 and	
0.6%	P).	At	day	45,	 rats	were	 subjected	 to	Nx.	 Just	before	performing	
the	first	Nx	step,	a	blood	sample	(Pre-Nx)	was	obtained	from	these	32	
rats	 to	 assess	 the	 influence	 of	 the	 caloric	 content	 of	 the	 diet	 on	
metabolic	 status	without	 the	 confounding	 effects	 of	 uremia.	 After	 the	
second	 step	 of	Nx,	 at	 day	 52,	 rats	were	 switched	 to	 a	 0.9%P	diet	 and	
treated	 with	 calcitriol,	 as	 described	 above.	 The	 caloric	 content	 of	 the	
diets	was	maintained	as	before	and	the	rats	continued	eating	either	NF	
or	HF	till	the	end	of	the	experiments.	Also,	after	Nx,	half	of	the	rats	from	
each	 group	 (NF	 and	 HF)	 were	 supplemented	 with	 VitE	 in	 the	 diet	
(30000	 mg/kg)	 and	 the	 other	 half	 were	 maintained	 on	 basic	 VitE	
requirements	 (27	 mg/kg).	 Thus,	 the	 four	 experimental	 groups	 were:	

















thoracic	 aorta,	 stomach	 and	 lungs	 were	 dissected	 and	 processed	 to	
study	mineral	content.	Vascular	and	soft	tissue	calcification	was	studied	
by	 histology	 and	 by	 measuring	 the	 tissue	 Ca	 content.	 Samples	 of	 the	
abdominal	 aorta,	 the	 right	 lung,	 and	 the	 stomach	 were	 fixed	 in	 10%	
buffered	 formalin	 and	 subsequently	 sectioned	 and	 stained	 for	
mineralization	by	the	Von	Kossa	method.	Another	portion	of	 the	aorta	
was	 demineralized	 in	 10%	 formic	 acid,	 and	 the	 arterial	 tissue	 Ca	
content	 was	 measured	 in	 the	 supernatant.	 Quantification	 of	 tissue	
mineral	 content	 was	 performed	 as	 described	 previously	 (Lopez	 et	 al.	
2006).	Briefly,	the	stomach	and	the	left	lung	from	each	rat	were	placed	
into	separate	50-ml	tubes.	Twenty	milliliters	of	150	mM	HCl	was	added	
to	 each	 tube.	 The	 tubes	 were	 mixed	 by	 inversion	 for	 24	 h	 at	 room	
temperature,	and	Ca	was	measured	in	the	acid	extract.	Ca	concentration	
in	 the	acid	 extracts	was	measured	by	 spectrophotometry	 (BioSystems	
SA,	Barcelona,	Spain).	
	
	 Blood	 Chemistries.	 Blood	 for	 chemistry	 analyses	 was	
obtained	 either	 in	 anesthetized	 (inhaled	 sevofluorane)	 rats,	 from	 the	










analyzed	 using	 a	 Ciba-Corning	 634	 ISE	 Ca2+/pH	 Analyzer	 (Ciba-
Corning,	 Essex,	 England).	 Afterwards,	 plasma	 was	 separated	 by	
centrifugation	and	stored	at	–20°	C	until	assayed.	Plasma	creatinine,	P,	
glucose,	 total	 cholesterol,	 high	 density	 lipoprotein	 (HDL)	 cholesterol,	
low	 density	 lipoprotein	 (LDL)	 cholesterol	 and	 triglycerides	 were	
measured	 by	 spectrophotometry	 (BioSystems	 SA,	 Barcelona,	 Spain).	
ELISA	tests	were	used	to	quantify	plasma	FGF23	(Kainos	Laboratories,	
Tokyo,	 Japan)	 and	 parathyroid	 hormone	 (PTH)	 (Immutopics,	 San	
Clemente,	 CA).	 Radioimmunoassay	 was	 used	 in	 plasma	 samples	 to	
determine	insulin	(Millipore,	St.	Charles,	MO,	USA),	leptin	(Millipore,	St.	




(SE).	 The	 difference	 between	 means	 for	 two	 different	 groups	 was	
determined	by	 t-test;	 the	difference	between	means	 for	 three	or	more	
groups	 was	 assessed	 by	 Analysis	 of	 Variance	 (ANOVA).	 Fisher	 Least	
Significant	 Difference	 (LSD)	 test	was	 used	 as	 a	 post-hoc	 procedure.	 A	












(198.8±5.6	g)	and	 in	rats	 fed	HF	(202.5±5.1	g).	The	rats	 that	were	 fed	
HF	diets	did	not	increase	body	weight	because	they	ingested	less	food:	
10.7±0.4	 g/day	 than	 the	 rats	 fed	 NF	 diets:	 13.0±0.5	 g/day.	 The	
differences	 in	 food	 intake	 between	 NF	 and	 HF	 diets	 were	 significant	
(p<0.05).	 After	 Nx,	 body	 weight	 decreased	 both	 in	 rats	 fed	 NF	
(189.4±3.5	g)	and	in	rats	fed	HF	(178.5±3.1	g).	
	 No	 differences	 in	 plasma	 creatinine	were	 found	 between	 the	




fed	 HF	 diet,	 926±121pg/ml,	 than	 in	 rats	 fed	 NF	 diet,	 217±17	 pg/ml,	
p<0.05.	No	differences	 in	plasma	 leptin	and	PTH	were	 found	between	
rats	fed	NF	and	HF	diet.	Prior	to	Nx,	plasma	concentrations	of	calcitriol	
were	 decreased	 in	 rats	 fed	 HF,	 11.3±1.2	 pg/ml,	when	 compared	with	
rats	fed	NF,	77.7±9.2	pg/ml,	p<0.001.		
	 Nephrectomy	 resulted	 in	 an	 increase	 in	 creatinine	 in	 all	
experimental	 groups.	 At	 the	 time	 of	 sacrifice	 plasma	 creatinine	 was	
significantly	higher	in	rats	fed	HF	diet	(1.8±0.2	mg/dl)	than	in	rats	fed	
NF	 diet	 (1.3±0.1	 mg/dl).	 Treatment	 with	 VitE	 reduced	 plasma	
creatinine	 and	 the	 difference	 was	 significant	 in	 the	 rats	 fed	 NF	 diet	






(total,	 LDL	 and	 HDL)	 concentrations.	 Plasma	 triglycerides	 were	
decreased	 in	Nx	 groups	 and	 rats	 receiving	 supplemental	 VitE	 had	 the	









and	was	 higher	 in	 rats	 fed	HF	 diets	 than	 in	 rats	 fed	NF	 diets.	 Plasma	
PTH	 values,	 which	 in	 Nx	 rats	 were	 controlled	 by	 treatment	 with	
calcitriol,	 were	 not	 influenced	 by	 either	 diet	 caloric	 content	 or	 VitE	
supplementation.	 Uremic	 rats,	 that	 were	 treated	 with	 calcitriol,	 had	
mean	plasma	calcitriol	concentrations	ranging	from	48.5	to	64.6	pg/ml	
and	 no	 significant	 differences	 were	 found	 between	 the	 four	
experimental	groups	(Table	1).			
	 Rats	 fed	 HF	 diet	 showed	 substantial	 aortic	 calcification	 with	
calcium	 content	 that	was	 significantly	 higher	 than	 in	 rats	 fed	 NF	 diet	
(38.4±8.8	 mg/g	 tissue	 vs	 8.7±4.2	 mg/g	 tissue,	 p<0.001).	
Supplementation	with	VitE	reduced	aortic	calcium	content	in	rats	on	HF	
diets	 to	 16.5±1.4	 mg/g	 tissue	 (p=0.018).	 Differences	 in	 aortic	







































































































































































































































experimental	 groups.	 (B)	 Representative	 von	 Kossa	 stained	 aortic	 tissue	
sections	from	the	same	rats	where	mineral	deposits	are	depicted	by	the	brown	
pigment.	 Nx-NF	 =	 uremic	 rats	 treated	 with	 calcitriol	 (80	 ng/kg	 ip	 eod)	 fed	
normal	fat	diet	with	0.9%	phosphorus	(n=8),	Nx-NF-VitE	=	uremic	rats	treated	
with	calcitriol	(80	ng/kg	ip	eod)	fed	normal	fat	diet	with	0.9%	phosphorus	and	
supplemented	 with	 vitamin	 E,	 30000	 mg/kg	 (n=8),	 Nx-HF	 =	 uremic	 rats	





	 Mineral	deposition	 in	 stomach	and	 lung	was	 less	 severe	 than	

















Fig.	 3.	 (A)	Calcium	content	 (mg/g	of	 tissue)	 in	 the	 stomachs	of	 rats	 from	 the	
four	experimental	groups.	(B)	Representative	von	Kossa	stained	gastric	tissue	
sections	from	the	same	rats	where	mineral	deposits	are	depicted	by	the	brown	
pigment.	 Nx-NF	 =	 uremic	 rats	 treated	 with	 calcitriol	 (80	 ng/kg	 ip	 eod)	 fed	
normal	fat	diet	with	0.9%	phosphorus	(n=8),	Nx-NF-VitE	=	uremic	rats	treated	
with	calcitriol	(80	ng/kg	ip	eod)	fed	normal	fat	diet	with	0.9%	phosphorus	and	
supplemented	 with	 vitamin	 E,	 30,000	 mg/kg	 (n=8),	 Nx-HF	 =	 uremic	 rats	














Fig.	4.	 (A)	Calcium	content	(mg/g	of	 tissue)	 in	 the	 lungs	of	rats	 from	the	 four	
experimental	groups.	 (B)	Representative	von	Kossa	stained	pulmonary	 tissue	
sections	from	the	same	rats	where	mineral	deposits	are	depicted	by	the	brown	
pigment.	 Nx-NF	 =	 uremic	 rats	 treated	 with	 calcitriol	 (80	 ng/kg	 ip	 eod)	 fed	
normal	fat	diet	with	0.9%	phosphorus	(n=8),	Nx-NF-VitE	=	uremic	rats	treated	
with	calcitriol	(80	ng/kg	ip	eod)	fed	normal	fat	diet	with	0.9%	phosphorus	and	
supplemented	 with	 vitamin	 E,	 30000	 mg/kg	 (n=8),	 Nx-HF	 =	 uremic	 rats	













	 This	 study	 was	 designed	 to	 investigate	 the	 influence	 of	
supplementing	 VitE	 on	 the	 development	 of	 extraskeletal	 calcifications	
in	uremic	rats	fed	diets	with	HF	content.		Our	results	confirm	a	previous	




maintain	 a	 caloric	 intake	 similar	 to	 rats	 fed	NF	 (around	50	kcal/day),	
thus	no	increase	in	body	weight	and	plasma	leptin	concentrations	was	
observed	 in	 rats	 fed	 HF.	 This	 allowed	 to	 study	 the	 effect	 of	 the	 fat	
content	 of	 the	diet	 independent	 of	 obesity-mediated	mechanisms	 (e.g.	
adipokines	and	other	inflammatory	mediators	released	by	fat	tissue).	At	
the	time	of	Nx	the	animals	fed	HF	diet	were	not	obese	but	they	showed	
biochemical	 signs	 of	 metabolic	 syndrome:	 hyperglycemia,	
hypertriglyceridemia	 and	 increased	 LDL.	 At	 this	 stage,	 with	 a	
background	 of	 metabolic	 changes	 induced	 by	 high	 caloric	 intake,	 we	
had	the	opportunity	to	explore	the	impact	of	renal	failure	on	VC	and	the	
influence	of	VitE.		
	 The	 dose	 of	 vitamin	 E	 used	 in	 the	 experiments	 was	 chosen	
based	on	previous	studies	(Peralta-Ramírez	et	al.	2014).	Rats	 ingested	
around	300	mg	of	vitamin	E	per	day	which	is	the	upper	limit	of	what	is	
considered	 safe	 for	 long	 term	 administration	 of	 vitamin	 E	 to	 humans	
(Rutkowsky	 and	 Grzegorczyk,	 2012).	 Although	 it	 is	 difficult	 to	
extrapolate	 the	effect	of	 this	dose	of	vitamin	E	 to	humans,	none	of	 the	
side	effects	described	in	people	after	vitamin	E	overdose	(diarrhea,	skin	
inflammation,	 hyperglycemia,	 hyperlipidemia)	 were	 observed	 in	 the	
present	study.		

















for	 the	 deleterious	 effect	 of	 HF	 diets	 on	 VC	 in	 uremic	 rats.	 When	
compared	with	a	earlier	report	in	which	genetic	obese	Zucker	rats	fed	a	
NF	 diet	 were	 subjected	 to	 the	 same	 experimental	 protocol,	 VC	 was	
much	more	severe	in	the	wild	type	rats	fed	HF	diet	of	the	current	study	
(Peralta-Ramírez	et	al.	2014).	 In	 fact,	 the	present	 study	was	originally	
designed	 to	 last	4	weeks	after	Nx	(same	time	 frame	than	 the	previous	






very	 low	 plasma	 calcitriol	 concentrations.	 A	 decrease	 in	 plasma	
calcitriol,	 without	 changes	 in	 plasma	 calcidiol,	 has	 been	 previously	
reported	in	rats	with	normal	renal	function	after	feeding	HF	diets	(Raya	
et	 al.	 2016).	 Since	 FGF23	 is	 known	 to	 decrease	 calcitriol	 synthesis	
through	 inhibition	 of	 1-alpha-hydroxylase	 activity	 in	 the	 kidney	
(Shimada	 et	 al.	 2004),	 these	 low	 calcitriol	 concentrations	 have	 been	
linked	to	the	increase	in	FGF23	elicited	by	HF	diets	(Raya	et	al.	2016).	In	
uremic	rats	calcitriol	should	be	further	reduced	by	the	decrease	in	renal	
mass	 and	 by	 the	 elevation	 in	 FGF23	 secondary	 to	 kidney	 disease	
(Rodriguez	 et	 al.	 2014).	 Vitamin	 D	 deficiency	 is	 associated	 with	
cardiovascular	disease	(Dobnig	et	al.	2008;	Norman	and	Powell,	2014;	
Parker	 et	 al.	 2010)	 and	 calcitriol	 treatment	 has	 been	 reported	 to	
improve	survival	of	CKD	patients	(Messa	et	al.	2015;	Zheng	et	al.	2013).	









results	of	 this	study	with	previous	data	 in	which	rats	 fed	HF	were	not	
treated	with	calcitriol	(Raya	et	al.	2016),	calcifications	were	much	more	
severe	 after	 calcitriol	 treatment.	 Therefore,	 the	 results	 of	 this	 study	
demonstrate	 that	even	 though	rats	 fed	HF	diets	have	very	 low	plasma	
calcitriol	concentrations,	treatment	with	calcitriol	at	doses	sufficient	to	
control	 secondary	 hyperparathyroidism	 is	 clearly	 deleterious.	 The	
negative	actions	of	calcitriol	are	probably	related	to	an	increased	P	load	
in	 animals	 with	 impaired	 P	 excretion	 derived	 from	 feeding	 HF	 diets	
(Raya	 et	 al.	 2016),	 which	 would	 override	 any	 beneficial	 effect	 that	
restoring	plasma	calcitriol	concentrations	may	have	on	vascular	health.	
In	 fact,	 the	data	of	 this	 study	 raise	 the	 intriguing	question	of	whether	
the	decrease	in	plasma	calcitriol	observed	after	feeding	HF	diets	might	
act	 as	 a	 protective	 mechanism	 in	 rats	 that	 already	 have	 difficulty	 in	
excreting	P.	
	 The	decrease	 in	phosphate	 levels	 in	uremic	 rats	 treated	with	
vitamin	 E	 is	 probably	 related	 to	 the	 reduction	 in	 extraskeletal	
calcification:	nephrocalcinosis	was	 less	 severe	 in	 animals	 treated	with	
vitamin	E	 thus	 allowing	 their	 remnant	kidneys	 to	be	more	efficient	 in	
phosphate	excretion.	
	 The	mechanisms	 to	explain	 the	detrimental	effect	of	HF	diets	
on	 VC	 are	 probably	 multifactorial.	 In	 previous	 studies	 with	 obese	
Zucker	 rats	 we	 have	 shown	 that	 oxidative	 stress	 plays	 an	 important	
role	in	obesity-associated	VC	(Peralta-Ramírez	et	al.	2014).	The	results	
of	 the	present	study	also	support	a	role	of	oxidative	stress	 in	HF	diet-
induced	 calcifications,	 because	 treatment	 with	 VitE	 substantially	
decreased	VC.	In	addition	to	any	direct	pro-oxidant	action	of	feeding	HF,	
HF	diet-induced	P	retention	may	also	contribute	to	oxidative	stress	(Di	
Marco	 et	 al.	 2008).	 Thus,	 VitE	 treatment	 may	 help	 to	 modulate	 the	
adverse	 pro-oxidant	 effects	 of	 P	 retention	 secondary	 to	 feeding	 HF.	












	 In	 conclusion,	 uremic	 rats	 fed	 HF	 diets	 develop	more	 severe	
extraosseous	 calcifications	 than	 their	 normocaloric-fed	 counterparts	
and	dietary	VitE	supplementation	protects	against	uremic	calcifications	
in	 rats	 fed	 HF	 diets.	 Thus,	 eating	 energy-rich	 foods	 should	 be	
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	 This	 study	 was	 designed	 to	 evaluate	 the	 influence	 of	
phosphorus	(P)	restriction	on	the	deleterious	effects	of	high	fat	diets	on	
mineral	metabolism.	 Twenty-four	 rats	were	 allotted	 to	 3	 groups	 (n=8	
each)	that	were	 fed	different	diets	 for	7	months.	Rats	 in	group	1	were	
fed	normal	fat-normal	P	(0.6%)	diet	(NF-NP),	rats	in	group	2	were	fed	
high	 fat-	normal	P	diet	(HF-NP)	and	rats	 in	group	3	were	 fed	high	 fat-
low	P	(0.2%)	diet	(HF-LP).		
	 Blood,	 urine	 and	 tissues	 were	 collected	 at	 the	 end	 of	 the	
experiments.	When	compared	with	the	control	group	(NF-NP),	rats	fed	
HF	 diets	 showed	 increases	 in	 body	 weight,	 and	 in	 plasma	
concentrations	 of	 triglycerides	 and	 leptin,	 and	 decreased	 plasma	
calcitriol	 concentrations.	 In	 rats	 fed	 HF-NP	 plasma	 fibroblast	 growth	
factor	23	(FGF23)	was	higher	(279.6±39.4	pg/ml	vs	160.6±25.0	pg/ml,	
p=0.018)	and	renal	klotho	(ratio	klotho/GAPDH)	was	lower	(0.75±0.06	
vs	 1.06±0.08,	 p<0.01)	 than	 in	 rats	 fed	 NF-NP.	 Phosphorus	 restriction	
did	not	normalize	plasma	FGF23	or	renal	klotho;	in	fact,	rats	fed	HF-LP,	
that	 only	 ingested	 an	 average	 of	 22.9	mg/day	 of	 P,	 had	 higher	 FGF23	
(214.7±32.4	 pg/ml)	 concentrations	 than	 rats	 fed	 NF-NP	 (160.6±25.0	
pg/ml),	that	ingested	and	average	of	74.4	mg/day	of	P	over	a	7	month	
period.	In	conclusion,	our	results	demonstrate	that	severe	P	restriction	













	 Obesity	 and	 its	 related	 metabolic	 complications	 represent	 a	
major	health	concern,	not	only	due	to	their	influence	on	morbidity	and	
mortality	but	also	for	the	high	healthcare	cost	associated	to	this	disease	
(Popkin	 et	 al.	 2012;	 Wang	 et	 al.	 2011).	 A	 major	 factor	 in	 the	
development	of	obesity	 is	excessive	caloric	 intake	which	 is	 favored	by	
the	ingestion	of	energy-dense	processed	foods	(fast	food).	In	addition	to	
their	 high	 caloric	 concentration,	 processed	 foods	 are	 often	 rich	 in	
phosphate	 (P)	 (Sarathy	 et	 al.	 2012).	 Phosphate	 is	 a	 common	 food	
additive	and	the	 inorganic	P	added	to	processed	 foods	 is	more	readily	
absorbed	than	organic	P	(Uribarri	and	Calvo,	2003).		Moreover,	the	high	
fat	 content	 of	 many	 fast	 foods	 also	 enhances	 intestinal	 P	 absorption	
(Frommelt	 et	 al.	 2014).	 Therefore,	 individuals	 eating	 fast	 food	 often	
ingest	an	overload	of	P	that	must	be	excreted	by	the	kidney	to	maintain	
P	homeostasis.	
	 Fibroblast	 growth	 factor	23	 (FGF23)	 is	 a	major	phosphaturic	
hormone.	In	the	kidney,	FGF23	promotes	P	excretion	after	binding	to	its	










klotho	 after	 feeding	 high	 fat	 diet.	 Klotho	 down-regulation	 generates	
tubular	 resistance	 to	 FGF23	 and	 thus	 more	 FGF23	 is	 needed	 for	 P	
excretion	(Kanbay	et	al.	2017).	Additionally,	a	recent	study	has	shown	
that	 an	 excessive	 tubular	 load	 of	 P	 down-regulates	 the	 expression	 of	














of	 high	 fat	 diets	 on	 mineral	 metabolism.	 Additionally,	 since	 previous	
studies	 (Raya	 et	 al.	 2016)	 were	 of	 short	 duration	 (1	 month),	 a	











	 Ethics	 approval.	 All	 experimental	 protocols	 were	 reviewed	




following	 the	 normal	 procedures	 directing	 animal	 welfare	 (Real	
Decreto	 223/88,	 BOE	 of	 18	 of	 March)	 and	 adhered	 to	 the	
recommendations	included	in	the	Guide	for	Care	and	Use	of	Laboratory	
Animals	 (US	 Department	 of	 Health	 and	 Human	 Services,	 NIH)	 and	
European	 laws	 and	 regulations	 on	 protection	 of	 animals,	 under	 the	
advice	of	specialized	personnel.	
	
	 Animals	 and	 diets.	 Twenty-four	 2	 months-old	 Wistar	 rats,	
provided	by	the	Animal	Housing	Facilities	of	the	University	of	Cordoba	
(Cordoba,	 Spain),	 were	 housed	 with	 a	 12h/12h	 light/dark	 cycle.	
Appropriate	 measures	 were	 taken	 to	 ensure	 animal	 welfare	 and	 to	
address	the	basic	behavioral	and	physiological	needs	of	rats.		
	 Two	 diets	 with	 normal	 P	 (NP=0.6%)	 were	 used	 in	 the	
experiments:	 normal	 fat	 content	 diet	 (NF-NP)	 with	 a	 5%	 fat	
concentration	 that	 provided	 Metabolizable	 Energy	 =	 3518	 kcal/kg	
(Altromin	 C	 1090-10,	 AltrominSpezialfutter	 GmbH,	 Germany)	 and	 a	
high	 fat	 content	 diet	 (HF-NP)	 with	 a	 35%	 fat	 concentration	 that	





	 Experimental	 design.	 Rats	 were	 allotted	 to	 3	 groups	 (n=8	
each)	which	were	 fed	ad	 libitum	 the	study	diets	 for	7	months.	Rats	 in	









housed	 in	 metabolic	 cages,	 allowing	 daily	 control	 of	 food	 and	 water	
intake	and	collection	of	urine.	At	 the	end	of	 the	experiment,	 rats	were	
sacrificed	 by	 exsanguination	 under	 general	 anesthesia	 (inhaled	
sevoflurane)	to	obtain	blood	and	tissue	samples.		
	
	 Blood	 chemistries.	 Blood	was	 collected	 from	 the	 abdominal	
aorta	at	the	time	of	sacrifice.	Blood	glucose	was	measured	immediately	
after	collection	with	a	blood	glucose	meter	 (Bayer	Consumer	Care	AG,	
Basel,	 Switzerland).	 	 Afterwards,	 plasma	 was	 separated	 by	
centrifugation	 and	 stored	 at	 –20°	 C	 until	 assayed.	 Plasma	
concentrations	 of	 total	 cholesterol,	 triglycerides,	 urea,	 creatinine,	
calcium	 and	 phosphorus	 were	 measured	 by	 spectrophotometry	
(BioSystems	 SA,	 Barcelona,	 Spain).	 ELISA	 tests	were	 used	 to	 quantify	
plasma	intact	FGF23	(Immutopics,	San	Clemente,	CA),	 leptin	(Millipore	
Corporation,	 Billerica,	 MA,	 USA),	 tumor	 necrosis	 factor	 alpha	 (TNFα)	
(eBioscience,	 Bender	 MedSystems	 GmbH,	 Vienna,	 Austria)	 and	
parathyroid	 hormone	 (PTH)	 (Immutopics,	 San	 Clemente,	 CA).	
Radioimmunoassay	 (Immunodiagnostic	 Systems	 Ltd,	 Boldon,	 UK)	was	
used	 in	 plasma	 samples	 to	 determine	 1,25-dihydroxyvitamin	 D	
(calcitriol).		
	





Kidney	 tissue	 was	 disrupted	 using	 liquid	 nitrogen	 and	 grinded	
thoroughly	 with	 a	 mortar.	 Renal	 total	 RNA	 was	 extracted	 with	 using	
chloroform	and	isopropanol	precipitation	method	and	a	treatment	with	
DNAse	 I	 amplification	 Grade	 (Sigma-Aldrich)	 and	 quantified	 by	










USA).	 RT-PCR	 was	 performed	 in	 one	 step,	 with	 the	 QuantiTect	 SYBR	
Green	 RT-PCR	 kit	 (Qiagen	 GmbH,	 Hilden,	 Germany)	 according	 to	 the	
manufacturer’s	 protocol.	 Rat	 primers	 for	 membrane	 Klotho	 were	
designed	with	 the	 free	 Oligo	 7	 software	 (http://www.oligo.net/),	 and	
the	sequence	is:		
	
	 Results	were	 normalized	 to	 that	 of	 GAPDH.	 Quantification	 of	
relative	expression	was	determined	by	the	2∆(∆CT)	method.		
	
	 Protein	 extraction	 and	 Western	 blot	 analysis.	 Proteins	
were	isolated	from	renal	tissue	by	using	a	lysis	buffer	containing	HEPES	
(10	mmol/l),	KCl	(10	mmol/l),	EDTA	(0.1	mmol/l),	EGTA	(0.1	mmol/l),	
DTT	 (1	 mmol/l),	 PMSF	 (0.5	 mmol/l),	 protease	 inhibitor	 cocktail	 (70	
μg/ml),	 and	 I-Gepal	 CA-630	 (0.6%),	 pH	 7.9	 (Sigma	 Aldrich,	 St.	 Louis,	
MO).	 Protein	 concentration	was	 determined	 by	 Bradford	method.	 For	
Western	Blot	analysis,	50	μg	of	protein	(klotho)	or	100	μg	(NaPiIIa)	of	
protein	 were	 electrophoresed	 on	 a	 10%	 SDS-polyacrilamide	 gel	
(Invitrogen,	Carlsbad,	CA)	and	electrophoretically	transferred	(Transfer	
Systems,	 BioRad,	 Hercules,	 CA)	 from	 the	 gels	 onto	 nitrocellulose	




nonspecific	 binding.	 Membranes	 were	 then	washed	with	 TTBS	 buffer	














anti-NaPiIIa	 antibody	 (Abcam	 plc,	 Cambridge,	 UK;	 1	 µg/ml).	 The	
membranes	 were	 then	 washed	 with	 TTBS	 buffer	 and	 immunolabeled	
using	 a	 peroxidase-conjugated	 secondary	 antibody	 (1:5000	 dilution;	
Santa	 Cruz	 Biotechnology	 Inc,	 Santa	 Cruz,	 CA).	 Finally,	 they	 were	
revealed	 on	 autoradiographic	 film	 using	 ECL	 Plus	 Western	 Blotting	
Detection	System	(GE	Healthcare,	Piscataway,	NJ).	GAPDH	was	used	as	
housekeeping	protein	to	ensure	equal	loading	of	the	gels.	Protein	levels	
were	 quantified	 using	 ImageJ	 software	 (National	 Institutes	 of	 Health,	
Bethesda,	MD).	
	
	 Renal	 Histopathology.	 Kidney	 tissue	 samples	 were	 fixed	 in	
10%	buffered	formalin,	embedded	in	paraffin,	sectioned	and	processed	
for	 staining	 with	 hematoxylin	 and	 eosin	 (H&E),	 periodic	 acid-Schiff	
(PAS),	Masson’s	Trichrome	and	Von	Kossa	stains.	Lesions	were	scored	
using	a	semi	quantitative	scale	graded	from	0-3:	0	(absent),	1	(slight),	2	
(moderate)	 or	 3	 (severe).	 This	 scale	 was	 constructed	 by	 a	 previous	
scanning	 of	 all	 the	 samples	 under	 study	 in	 which	 the	 more	 severe	
lesions	 were	 identified	 and	 were	 assigned	 a	 value=3.	 For	 statistical	
analysis	 lesions	 were	 grouped	 into	 three	 categories:	 a)	 glomerular	
lesions	 (glomerular	 retraction	 and	 sclerosis),	 b)	 tubular	 lesions	
(tubular	 atrophy,	 tubular	 hyperplasia	 and	 thickening	 of	 basement	




















that	 was	 more	 accentuated	 in	 the	 groups	 fed	 a	 HF	 diet.	 Phosphorus	
restriction	 attenuated	 the	 increase	 in	 body	weight	 in	 rats	 fed	HF,	 but	






experiments	 in	 rats	 (n=8	 per	 group)	 fed	 diets	 with	 normal	 fat	 and	 normal	
phosphorus	 (NF-NP),	 high	 fat	 and	 normal	 phosphorus	 (HF-NP)	 and	 high	 fat	
and	low	phosphorus	(HF-LP).	ap<0.05	vs	NF-NP.	
	
	 Blood	 glucose	 and	 cholesterol	 concentrations	 were	 not	
different	between	groups.	However,	plasma	triglycerides	were	higher	in	
rats	 fed	HF	 than	 in	 rats	 fed	NF:	HF-NP	=	0.94±0.1	mmol/l	vs	NF-NP	=	
0.58±0.1	 mmol/l,	 p=0.002.	 Phosphorus	 restriction	 led	 to	 a	 non-
significant	 decrease	 in	 triglyceride	 concentrations	 in	HF	 rats.	 	 Plasma	
leptin	concentrations	were	also	higher	(p<0.05)	in	rats	fed	HF	(5.2±0.8	










Table	 1.	 Blood	biochemistry.	 Plasma	 concentrations	 of	 parameters	 related	 to	
energy	metabolism,	mineral	metabolism,	 renal	 function,	 and	 inflammation	 in	
rats	 fed	 diets	with	 normal	 fat	 and	 normal	 phosphorus	 (NF-NP),	 high	 fat	 and	
normal	 phosphorus	 (HF-NP)	 and	 high	 fat	 and	 low	 phosphorus	 (HF-LP).	
ap<0.05	vs	NF-NP,	bp<0.05	vs	HF-NP.	
	
	 Plasma	 Ca	 concentrations	 were	 not	 different	 in	 the	 study	
groups.	Plasma	P	was	not	influenced	by	the	caloric	content	of	the	diet:	
NF-NP	 =	 1.2±0.1	 mmol/l	 vs	 HF-NP	 =	 1.0±0.1	 mmol/l.	 Phosphorus	
restriction	 did	 not	 modify	 plasma	 P	 in	 rats	 fed	 HF	 (1.0±0.1	 mmol/l).	
Plasma	 PTH	 was	 not	 different	 in	 HF	 vs	 NF	 groups	 but	 tended	 to	 be	
decreased	 in	 the	 HF-LP	 group.	 Plasma	 calcitriol	 concentrations	 were	
higher	 in	 rats	 fed	 normal	 fat:	 NF-NP	 =	 50.7±21.5	 pmol/l	 vs	 HF-NP	 =	
5.3±0.9	pmol/l,	p<0.05.	Phosphorus	restriction	led	to	a	modest	increase	
in	plasma	calcitriol	in	rats	fed	high	fat,	HF-LP	=	12.3±1.9	pmol/l,	p<0.05	
vs	HF-NP.	No	 significant	 differences	 in	 either	 urea	 or	 creatinine	were	
observed	 between	 the	 experimental	 groups,	 although	 rats	 fed	HF	 had	









Glucose	(mmol/l)	 6.43	±	0.3	 5.54	±	0.3	 5.76	±	0.2	
Total	Cholesterol	(mmol/l)	 1.31	±	0.2	 1.28	±	0.2	 1.37	±	0.1	
Triglycerides	(mmol/l)	 0.58	±	0.1	 0.94	±	0.1a	 0.63	±	0.0	
Leptin	(ng/ml)	 3.9	±	0.5	 5.2	±	0.8a	 5.8	±	0.5a	
Calcium	(mmol/l)	 2.3	±	0.1	 2.2	±	0.1	 2.2	±	0.1	
Phosphorus	(mmol/l)	 1.2	±	0.1	 1.0	±	0.1	 1.0	±	0.1	
PTH	(pmol/l)	 29.8	±	6.5	 27.5	±	6.0	 21.0	±	1.6	
Calcitriol	(pmol/l)	 50.7	±	21.5	 5.3	±	0.9a	 12.3	±	1.9a	
Urea	(mmol/l)	 3.98	±	0.51	 4.98	±	0.54	 4.99	±	0.44	
Creatinine	(µmol/l)	 65	±	4	 73	±	3	 81	±	2	












pg/ml	 and	 NF-NP,	 160.6±25.0	 pg/ml	 (p=0.018).	 A	 non-significant	
tendency	to	decreased	FGF23	was	detected	in	P	restricted	rats	(Fig	2A).	
	 Renal	klotho,	both	at	the	mRNA	and	protein	levels,	changed	in	
accordance,	 but	 in	 opposite	 direction,	 to	 FGF23.	 Thus,	 mRNA	 (ratio	
klotho/GAPDH)	was	lower	(p<0.01)	in	rats	fed	HF-NP	(0.65±0.09)	than	
in	rats	 fed	NF-NP	(1.06±0.13).	A	significant	(p<0.01)	decrease	 in	renal	
klotho	 protein	 (ratio	 klotho/GAPDH)	 was	 also	 found	 in	 the	 HF-NP	
group	 (0.75±0.06)	when	 compared	with	 the	NF-NP	group	 (1.06±0.08)	
(Fig	3).	
	 Urinary	excretion	of	P	was	higher	 (p<0.01)	 in	rats	 fed	HF-NP	
(33.5±1.7	mg/day)	than	in	rats	fed	NF-NP	(23.8±0.8	mg/day).	Rats	fed	
HF-LP	excreted	very	little	P	(3.5±0.6	mg/day),	p<0.01	vs	NP	groups	(Fig	
2B).	 Renal	 NaPiIIa	 (ratio	 NaPiIIa/GAPDH)	 was	 decreased	 (p<0.01)	 in	
rats	 fed	 HF-NP	 (0.59±0.05)	 when	 compared	 with	 rats	 fed	 NF-NP	
(1.04±0.04).	Phosphorus	restriction	restored	NaPiIIa	expression	in	rats	













normal	 phosphorus	 (NF-NP),	 high	 fat	 and	 normal	 phosphorus	 (HF-NP)	 and	
high	 fat	and	 low	phosphorus	(HF-LP).	 (B)	Urinary	excretion	of	P	(mg/day)	 in	
rats	 (n=8	 per	 group)	 fed	 diets	with	 normal	 fat	 and	 normal	 phosphorus	 (NF-
NP),	high	fat	and	normal	phosphorus	(HF-NP)	and	high	fat	and	low	phosphorus	
(HF-LP).	 (C)	 Expression	 of	NaPiIIa	 in	 the	 kidney	 of	 rats	 (n=8	 per	 group)	 fed	







































































































Fig.	 3.	 Renal	 klotho.	Klotho	mRNA	 (A)	 and	protein	 (B)	 in	 the	 kidneys	 of	 rats	
(n=8	 per	 group)	 fed	 diets	 with	 normal	 fat	 and	 normal	 phosphorus	 (NF-NP),	
high	 fat	 and	 normal	 phosphorus	 (HF-NP)	 and	 high	 fat	 and	 low	 phosphorus	
(HF-LP).	ap<0.05	vs	NF-NP.	
	 		
	 In	 rats	 fed	HF,	 the	 amount	 of	 P	 ingested	was	well	 correlated	














































































(A)	 P	 urine	 (r2=0.663,	 p<0.001),	 (B)	 P	 plasma	 (r2=0.004,	 p=0.806),	 and	 (C)	





glomeruli	was	 significantly	higher	 in	 rats	 fed	HF	and	P	 restriction	did	
not	 influence	 glomerular	 damage.	 Similarly,	 rats	 fed	HF	 showed	more	
tubular	atrophy	and	hyperplasia,	as	well	as	thickening	of	the	basement	
membrane	than	rats	fed	NF.	Phosphorus	restriction	tended	to	attenuate	
tubular	 lesions	 but	 the	 differences	 were	 not	 significant.	 Interstitial	

























































edema	and	 infiltrate	were	 also	more	prominent	 in	 rats	 fed	HF	and,	 in	





(Tubular	 lesions);	and	 interstitial	edema	and	 infiltrate	 (Interstitial	 lesions)	 in	
rats	 fed	 diets	with	 normal	 fat	 and	 normal	 phosphorus	 (NF-NP),	 high	 fat	 and	









Glomerular	lesions	 0.5	±	0.1	 1.1	±	0.3a	 1.3	±	0.4a	
Tubular	lesions	 0.1	±	0.1	 1.2	±	0.1a	 0.9	±	0.2a	












of	 time	 (7	months)	does	not	normalize	 the	elevated	circulating	FGF23	
levels	 induced	 by	 HF	 diets.	 These	 data	 indicate	 that	 the	 deleterious	
effects	of	high	 fat	diet	on	the	FGF23/klotho	axis	are	not	eliminated	by	
reduced	P	intake.	
	 The	 increase	 in	 plasma	 concentrations	 of	 FGF23	 detected	 in	
the	 present	 study	 after	 feeding	 HF	 diets	 confirms	 previous	 results	
which	 were	 obtained	 over	 a	 much	 shorter	 period	 of	 time	 (1	 month)	




	 As	 it	 has	 been	 previously	 reported,	 the	 mechanism	 for	
increased	FGF23	in	rats	fed	HF	diets	is	likely	related	to	the	decrease	in	
renal	klotho.	Renal	klotho	has	been	 shown	 to	decrease	 in	 response	 to	
HF	diets	both	 in	Wistar	 rats	 (Raya	 et	 al.	 2016)	 and	 in	APoE	knockout	
mice	 (Sastre	 et	 al.	 2013).	 When	 renal	 klotho	 is	 decreased,	 tubular	
resistance	 to	 FGF23	 action	 ensues	 and	 more	 FGF23	 is	 needed	 to	
maintain	 phosphaturia,	 consequently	 resulting	 in	 an	 increase	 in	
circulating	 levels	 of	 FGF23	 (Kanbay	 et	 al.	 2017).	 In	 addition,	 feeding	
high	fat	and	obesity	may	elicit	systemic	inflammation	(Poret	et	al.	2018)	
and	 renal	 injury	 (Wickman	 and	 Kramer,	 2013)	 which	 could	 also	
influence	FGF23	(Kanbay	et	al.	2017).	In	the	present	study,	a	tendency	
to	 increased	TNFα	 and	minor	 renal	 lesions	were	 observed	 in	 rats	 fed	












(Muñoz-Castañeda	 et	 al.	 2017),	 it	 was	 hypothesized	 that	 reducing	 P	
intake,	 by	 feeding	 a	 0.2%	 P	 diet,	 would	 restore	 renal	 klotho	 and	
decrease	circulating	FGF23	levels	in	rats	fed	HF.	Our	results	show	that	P	
restriction	resulted	in	a	discrete	increase	in	renal	klotho	expression	in	
rats	 fed	 HF	 diets.	 A	 small	 and	 non-significant	 decrease	 in	 circulating	





overcame	 the	 inhibitory	 effect	 of	 P	 restriction	 and	 the	 present	 data	




concentrations	 than	 rats	 fed	NF-NP,	 that	 ingested	and	average	of	74.4	
mg/day	of	P	over	a	7	month	period.	
	 The	 main	 physiologic	 role	 of	 FGF23	 is	 to	 enhance	
phosphaturia	 (Kuro-o,	 2010)	 and	 this	 is	 accomplished	 by	 down-
regulating	 P	 transporters,	 mainly	 NaPiIIa,	 in	 the	 renal	 tubule.	 The	
reduction	 of	 NaPiIIa	 restricts	 P	 reabsorption	 and	 promotes	 urinary	
excretion	of	P	(Biber	et	al.	2009).	In	our	study,	NaPiIIa	was	regulated	in	
accordance	to	the	changes	in	FGF23.	Therefore,	feeding	HF	resulted	in	a	
significant	 decrease	 in	 NaPiIIa	 and	 increased	 urinary	 excretion	 of	 P.	
Interestingly,	in	rats	fed	HF,	P	restriction	increased	NaPiIIa	to	almost	to	
the	same	level	than	in	rats	fed	NF,	contrary	to	what	was	observed	with	
FGF23.	These	data	 are	 in	 agreement	with	previous	 reports	 suggesting	
that,	 in	 addition	 to	 FGF23,	 NaPiIIa	 may	 be	 directly	 regulated	 by	 P	
(Bourgeois	et	al.	2013).		
	 It	 is	 surprising	 that	 high	 fat	 intake	 has	 such	 a	 profound	









and	 as	 yet	 not	 clarified,	 physiologic	 actions	 of	 FGF23.	 FGF23	 plays	 a	
pivotal	 role	 in	 mineral	 metabolism	 and	 is	 consistently	 increased	 in	
patients	with	 chronic	 kidney	 disease	 (Kovesdy	 and	Quarles,	 2016).	 In	
addition,	 FGF23	 has	 been	 reported	 to	 be	 increased	 in	 obese	 people	
(Marsell	 et	 al.	 2009)	 and	 a	 recent	 study	 identified	 energy	 intake	 as	 a	
potential	predictor	of	plasma	FGF23	concentrations	(di	Giusseppe	et	al.	
2015).	 In	 this	 context	 it	 is	 relevant	 to	 point	 out	 that	 klotho	 has	 been	
shown	 to	 be	 implicated	 in	 energy	metabolism	 (Miyazaqui	 et	 al.	 2010;	
Razzaque,	2012).	
	 Parameters	 related	 to	 energy	 intake	 may	 influence	 the	
increase	 in	 FGF23	 after	 feeding	 HF	 diets.	 One	 factor	 that	 might	 be	
relevant	is	the	increase	in	plasma	leptin	concentrations	observed	in	rats	
fed	 HF.	 Leptin	 has	 been	 reported	 to	 stimulate	 FGF23	 secretion	 by	










	 A	 remarkable	 finding	 of	 this	 study	 is	 that	 plasma	
concentrations	 of	 P	did	not	 change	 in	 rats	 fed	different	 amounts	 of	 P.	
Plasma	P	was	maintained	constant	by	adjusting	urinary	excretion	of	P	
which	showed	an	excellent	correlation	with	P	ingestion.	However,	 it	 is	
interesting	 to	note	 that	FGF23	had	a	poor	 correlation	with	 ingested	P	
and	 that	 many	 rats	 fed	 HF-LP	 had	 high	 FGF23	 concentrations,	 even	





















































deficiency,	 inflammation,	 insulin	 resistance,	 left	 ventricular	
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reduced	 renal	 function	 (1/2	 nephrectomy)	 fed	 normal	 phosphorus	





increase	 in	both	 the	plasma	concentrations	of	 fibroblast	growth	 factor	
23	and	the	bone	expression	of	fibroblast	growth	factor	23.			
	






















































	 To	 investigate	 the	 effect	 of	 feeding	 a	 high	 fat	 (HF)	 diet	 on	
phosphorus	 (P)	 balance,	 studies	 were	 conducted	 in	 rats	 with	 normal	
renal	 function	 fed	 normal	 (0.6%)	 and	 elevated	 (1.2%)	 P	 and	 in	
uninephrectomized	 rats	 fed	0.6%	P.	Rats	were	 fed	either	a	normal	 fat	
(NF)	or	HF	diet	 for	30	days.	At	the	end	of	the	experiments	rats	 fed	HF	
did	not	differ	from	rats	fed	NF	in	body	weight,	renal	function	and	lipid	




FGF23	was	 likely	 secondary	 to	 a	 decrease	 in	 renal	 expression	 of	 alfa-
klotho	observed	in	the	rats	fed	HF.	All	rats	fed	HF	also	showed	reduced	
plasma	calcitriol	and	normal	plasma	calcidiol	concentrations.	In	uremic	
rats	 (5/6	 nephrectomy)	 fed	 0.9%	 P,	 HF	 diet	 intake	 resulted	 in	 more	
severe	extraskeletal	calcifications	than	in	their	NF	fed	counterparts.	
	 In	 a	 second	 set	 of	 experiments,	 the	 influence	 of	 HF	 diet	 on	
vascular	and	extraskeletal	calcification	was	evaluated	with	more	detail.	
In	 this	 study	 rats	were	 fed	 either	NF	or	HF	diets,	with	0.6%	P,	 for	45	
days,	 before	 performing	 5/6	 nephrectomy.	 	 After	 nephrectomy,	 rats	
were	switched	to	diets	(NF	or	HF)	with	1.2%	P	and	were	treated	with	
calcitriol	 (80	ng/kg	on	alternate	days).	Half	of	 the	rats	 in	each	 feeding	
schedule	 (NF	 or	 HF)	 were	 supplemented	 with	 vitamin	 E	 (30000	
mg/kg).	 	 Prior	 to	nephrectomy,	 after	45	days	 feeding	HF,	 rats	did	not	
increase	 body	 weight	 but	 showed	 moderate	 hyperglycemia	 and	
dyslipidemia.	As	in	previous	experiments,	plasma	FGF23	was	increased	
and	 calcitriol	was	 decreased	 in	 rats	 fed	HF.	 After	Nx,	 rats	 fed	HF	diet	
showed	substantial	extraskeletal	calcification.	Uremic	rats	fed	HF	diets	
developed	more	severe	extraosseous	calcifications	than	uremic	rats	fed	









	 To	 evaluate	 whether	 reducing	 P	 load	 by	 feeding	 a	 diet	 with	
low	P	content	would	prevent	the	increase	in	FGF23	elicited	by	high	fat	
diet,	 rats	were	 fed	HF	diets	with	normal	 (0.6%)	or	 low	(0.2%)	P	 for	7	
months.	 At	 the	 end	 of	 the	 experiments,	when	 compared	with	 rats	 fed	
NF,	rats	fed	HF	had	increased	their	body	weight	and	their	plasma	levels	
of	triglycerides	and	leptin.	In	addition,	these	rats	showed	a	tendency	to	
reduced	 renal	 function	 and	 increased	 inflammatory	 status.	 As	 in	
previous	 experiments,	 feeding	 HF	 resulted	 in	 increased	 plasma	
concentrations	 of	 FGF23	 and	 decreased	 plasma	 concentrations	 of	
calcitriol.	 Phosphorus	 restriction	 did	 not	 normalize	 the	 plasma	
concentrations	 of	 FGF23	 and	 did	 not	 restore	 the	 decreased	 levels	 of	
renal	alfa-klotho	in	rats	fed	HF.	 	When	comparing	the	groups	fed	0.6%	
P,	 urinary	 excretion	 of	 P	 was	 higher	 and	 renal	 expression	 of	 the	
sodium-phosphate	 co-transporter	 NaPiIIa	 was	 lower	 in	 rats	 fed	 HF.	
















alimentadas	 con	 AG	 no	 difirieron	 de	 las	 ratas	 alimentadas	 con	NG	 en	
peso	 corporal,	 función	 renal	 ni	 perfil	 lipídico.	 Cuando	 se	 compararon	
con	 ratas	 alimentadas	 con	 NG,	 las	 ratas	 alimentadas	 con	 AG	 que	
recibieron	 1,2%	 de	 P	 y	 las	 ratas	 uninefrectomizadas	 mostraron	




la	 expresión	 renal	 de	 alfa-klotho	 observado	 en	 las	 ratas	 alimentadas	
con	 AG.	 Todas	 las	 ratas	 alimentadas	 con	 AG	 también	 mostraron	
reducción	 de	 calcitriol	 plasmático	 y	 concentraciones	 normales	 de	
calcidiol	 en	 plasma.	 En	 ratas	 urémicas	 (nefrectomía	 5/6)	 alimentadas	
con	 0,9%	 de	 P,	 la	 ingesta	 de	 dieta	 AG	 dio	 lugar	 a	 calcificaciones	
extraesqueléticas	más	graves	que	en	las	alimentadas	con	NG.	




(Nx)	5/6.	Después	de	 la	Nx,	 las	 ratas	 se	 alimentaron	 con	dietas	 (NG	o	
AG)	 con	 1,2%	 de	 P	 y	 se	 trataron	 con	 calcitriol	 (80	 ng/kg	 en	 días	
alternos).	 La	mitad	 de	 las	 ratas	 de	 cada	 grupo	 de	 alimentación	 (NG	 o	
AG)	 se	 trataron	 con	 vitamina	E	 (30000	mg	 /	 kg).	Durante	 los	 45	 días	
previos	 a	 la	 Nx,	 las	 ratas	 no	 aumentaron	 el	 peso	 corporal,	 pero	
mostraron	 hiperglucemia	 moderada	 y	 dislipidemia.	 Como	 en	








ratas	 alimentadas	 con	 AG.	 Después	 de	 Nx,	 las	 ratas	 alimentadas	 con	
dieta	AG	mostraron	 calcificación	 extraesquelética	 sustancial.	 Las	 ratas	
urémicas	 alimentadas	 con	 dietas	 AG	 desarrollaron	 calcificaciones	
extraóseas	más	severas	que	las	ratas	urémicas	alimentadas	con	NG.	La	
suplementación	 dietética	 con	 vitamina	 E	 protege	 contra	 las	
calcificaciones	urémicas	en	ratas	alimentadas	con	dieta	AG.		





ratas	 alimentadas	 con	 AG	 aumentaron	 su	 peso	 corporal	 y	 sus	 niveles	
plasmáticos	 de	 triglicéridos	 y	 leptina.	 Además,	 estas	 ratas	 mostraron	
una	 tendencia	 a	 disminuir	 la	 función	 renal	 y	 aumentar	 el	 estado	
inflamatorio.	Como	en	experimentos	previos,	la	alimentación	de	AG	dio	
como	 resultado	 un	 aumento	 de	 las	 concentraciones	 plasmáticas	 de	
FGF23	 y	 una	 disminución	 de	 las	 concentraciones	 plasmáticas	 de	
calcitriol.	 La	 restricción	 de	 fósforo	 no	 normalizó	 las	 concentraciones	
plasmáticas	de	FGF23	y	no	restableció	 los	niveles	disminuidos	de	alfa-
klotho	 renal	 en	 ratas	 alimentadas	 con	 AG.	 Al	 comparar	 los	 grupos	
alimentados	 con	 0.6%	 P,	 la	 excreción	 urinaria	 de	 P	 fue	 mayor	 y	 la	
expresión	 renal	 del	 cotransportador	 de	 fósforo-sodio,	 NaPiIIa,	 fue	
menor	en	 las	ratas	alimentadas	con	AG.	La	excreción	urinaria	de	P	fue	
muy	baja	en	ratas	alimentadas	con	0,2%	de	P	aunque	estas	ratas	tenían	


















































































Energy-dense	 diets	 increase	 FGF23,	 lead	 to	 phosphorus	 retention	 and	
promote	vascular	calcifications	in	rats	
Ana	 I.	 Raya,	 Rafael	 Rios,	 Carmen	 Pineda,	 Maria	 E.	 Rodriguez-Ortiz,	 Elisa	 Diez,	






Vitamin	 E	 protects	 against	 extraskeletal	 calcification	 in	 uremic	 rats	 fed	
high	fat	diets.		






Phosphorus	 restriction	 does	 not	 prevent	 the	 increase	 in	 fibroblast	
growth	factor	23	elicited	by	high	fat	diet.		





















Quiero	 agradecer	 todo	 el	 esfuerzo	 y	 el	 apoyo	 incondicional	 de	 aquellas	
personas,	desde	las	 involucradas	directamente,	hasta	las	que	han	dejado	
su	 granito	 de	 arena,	 para	 “hornear	 y	 cocinar”	 mi	 tesis	 doctoral,	
culminando	esta	etapa	de	mi	vida	“a	priori”	académica,	para	iniciar	una	
vida	 profesional	 en	 la	 que	 todos	 han	 participado	 dirigiéndome,	
educándome	y	formándome	de	la	mejor	manera	posible.	
Al	Dr.	Escolástico	Aguilera	Tejero	agradecerle	su	confianza,	su	apoyo	y	su	
rigurosa	 profesionalidad,	 ha	 sido	 un	 ejemplo	 a	 seguir	 como	 persona	 e	
investigador	que	nunca	podré	olvidar.	
A	la	Dra.	Ana	Isabel	Raya	Bermúdez	agradecerle	su	inagotable	energía	y	
su	 indudable	 motivación	 y	 apoyo	 tanto	 laboral	 como	 personal	 y	 a	 su	
familia	 por	 todo	 su	 cariño	 y	 por	 tantos	 buenos	 momentos	 que	 nos	
permiten	seguir	el	día	a	día	
A	 la	 Dra.	 Carmen	 Pineda	 por	 la	 cantidad	 de	 horas	 de	 infatigable	
compañía,	apoyo	y	ayuda	que	siempre	me	ha	brindado.	Y	a	todas	aquellas	
personas	 que	 siempre	 han	 tenido	 un	 hueco	 para	 consultas,	 dudas	 o	
consejos,	como	los	Dres.	 Ignacio	López,	Mariano	Rodríguez,	 Juan	Muñoz,	




Durante	 mi	 formación	 ha	 sido	 imprescindible	 el	 apoyo	 científico	 de	
muchos	 organismos,	 tales	 como	 el	 Servicio	 de	 Animales	 de	
Experimentación	(SAEx)	y	el	Servicio	Científico	de	Apoyo	al	 Investigador	
(SCAI)	 de	 la	 Universidad	 de	 Córdoba	 cuyos	 facultativos	 y	 personal	
siempre	me	 han	 recibido	 cordial	 y	 amigablemente,	 muchas	 gracias	 por	
vuestro	tiempo.	
I	would	 like	 to	 address	 special	 thanks	 to	 the	 reviewers	 of	my	 thesis,	 for	





College	 of	 London	 (England)	 especially	 Dr.	 Robert	 Unwin,	 Dra.	 Joanne	
Marks;	Dr.	Grégory	Jacquillet,	Anne,	Evans,	Felice	and	Barbara.		
A	mis	padres	Rafael	Ríos	García	y	Manuela	Varo	 Jordano,	que	con	tanto	
tesón	 han	 sabido	 dejarme	 elegir	mi	 camino,	 pues	 sabían	 que	 eligiera	 el	
que	 eligiera	 ellos	 estarían	 siempre	 a	 mi	 lado	 para	 animarme	 o	
aconsejarme,		a	mis	hermanos	Cristina	Mª	Ríos	Varo	y	Miguel	Ángel	Ríos	
Varo	 que	 siempre	 me	 han	 acompañado	 y	 los	 que	 han	 mostrado	
innumerables	 momentos	 de	 alegría	 y	 orgullo	 que	 siempre	 me	 han	
impulsado	a	mejorar	y	mejorar.	
A	María	José	González	Anguiano	y	su	familia	quiero	agradecerles	toda	la	








teniendo	 que	 aguantar	 los	 malos	 y	 los	 buenos	 momentos	 de	 esta	
sacrificada,	 pero	 no	 menos	 placentera,	 vida	 científica.	 La	 compañía	 de	














































the	 "Instituto	 de	 Salud	 Carlos	 III",	 through	 the	 Research	 Grants	
PI14/00467	and	PI17/00169,	with	co-financing	from	European	Funds.	
	
	
	
	
	
Appendix	 Rafael	Ríos	Varo	
116	
	
	
	
	 	
	
	
	
	
